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Introduction 11 
Large bowel cancer is one of the leading causes of cancer death in 
the western world. Marked international differences in incidence rates 
suggests that environmental factors and especially dietary factors 
play an important role in the etiology of colonic cancer. It has been 
estimated that 90% of the geographic differences are based on 
dietary differences, with an increased risk for a high fat intake and a 
protective effect for dietary fiber. This protection of dietary fiber is 
based on several mechanisms, fecal bulking and colonic fermentation 
being the most important factors. Fecal bulking is related to water-
absorption of non-digested fiber constituents and results in an dilution 
of the fecal content and may contribute to a shortening of the colonic 
transit time. Due to both factors, the contact-time of potential 
hazardous substances in the colonic lumen will diminish. Part of fiber 
constituents can be degraded by colonic bacteria. This fermentation 
process results in the production of short chain fatty acids, which 
play an important role in intraluminal metabolism and in nutrition of 
colonocytes. The decrease in intracolonic pH, which is the result of 
short chain fatty acid production, may influence -amongst others- the 
transformation of primary into secondary bile acids. These acids can 
damage the mucosal cells and are thought to be co-mutagenic. 
Furthermore, the acid environment may result in precipitation of the 
bile acids. 
Studies in which a high-fiber diet was given to healthy volunteers, 
have been shown conflicting results. Partly, this is related to 
differences in physico-chemical properties between various fibers, 
resulting in important differences in water-holding capacity and 
fermentability. Furthermore, high-fiber diets have been shown less 
attractive to most western people. 
In contrast to the assumption that dietary starch is completely 
hydrolysed and absorbed in the small bowel, recent studies have been 
shown that a certain amount of starch, depending on processing, is 
resistant against small bowel digestion and may be fermented in the 
colon. In fact, it seems a more important source of fermentable 
substrate than fiber. As it is possible to incorporate this resistant 
starch in our normal diet, it seems an attractive alternative for fiber-
preparations in stimulating colonic fermentation and hopefully in the 
prevention of large bowel cancer. 
In the next chapter of this thesis, we will give an overview of the 
effects of fermentation on colonic metabolism, with respect to factors 
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involved in carcinogenesis. The influence of fiber on bile acid 
metabolism is described in chapter 3. To study the membrane-
damaging potential of bile acids to colonic mucosal cells, we 
developed a new cytotoxicity assay (chapter 4). An increased prolifer-
ation of the colonic mucosal cells, probably mediated by the cytotoxic 
effects of bile acids, has been shown to be a biomarker for large 
bowel carcinogenesis. We adapted a Proliferating Cell Nuclear 
Antigen-immunostaining technic to estimate proliferation in colonic 
mucosa (chapter 5). In chapter 6, we studied the in vitro fermenta 
bility of amylomaize, which is a maize-starch containing 62% 
resistant starch. In chapter 7 is demonstrated that consumption of 45 
g/d amylomaize results in a significant stimulation of colonic 
fermentation, and in chapter 8 we determinated the effects of 
amylomaize on cytotoxicity of feces, on bile acid metabolism and on 
colonic mucosal proliferation. 
Chapter 2 
The role of carbohydrate fermentatioi 
in colon cancer prevention 
Ivo P. van Munster and Fokko M. Nagengast. 
Scand J of Gastroenterology 1993; suppl 200: 80-86. 
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Abstract. 
Diet is an important factor in the development of colonic cancer. Fiber 
has been shown to decrease this risk. Part of this protective effect is 
probaly mediated by colonic fermentation. About 10% of starch in 
the normal diet escapes digestion and absorption in the small bowel, 
and is therefore called resistant starch. This is a considerably larger 
source of fermentable substrate than fiber in the diet and could thus 
contribute significantly to the prevention of this malignancy. Short 
chain fatty acids, produced during fermentation, reduce colonic pH, 
affecting the intraluminal concentration of the putative co-carcin-
ogenic secondary bile acids by precipitation, and by inhibition of their 
enzymatic formation from primary bile acids. The role of secondary 
bile acids in promoting colonic carcinogenesis is probably mediated by 
their cytotoxic effect on colonic mucosa, leading to a compensatory 
increase in proliferation. A hyperproliferative mucosa, having an 
enhanced sensitivity to mutagenic substances, is associated with an 
increased risk of colorectal cancer. Butyrate, one of the short chain 
fatty acids, could be significant as it has antineoplastic properties in 
vitro and in vivo. 
We conclude that fermentation is probably the key factor in the 
protective effect of fiber on colon carcinogenesis. Furthermore, 
consumption of resistant starch seems to be another way of stimula-
ting fermentation. 
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Introduction. 
The incidence of colon cancer varies largely between different popula-
tions. In western countries it is one of the most frequent cancers, but 
low incidence rates are observed in parts of South-America, Africa 
and Asia. Genetic factors may play a role in these differences, but it 
is widely accepted that environmental factors are the most important. 
It has been estimated that differences in diet may account for 90% of 
the variation in the incidence of colorectal cancer1. Epidemiological 
studies in Japan, a country with a traditionally low incidence of colon 
cancer, have shown that individuals, migrating to high risk countries, 
incurred the same high risk 2. This increased risk of colon cancer is 
supposedly mediated by dietary changes, from the low risk Japanese 
diet to a high risk western diet. Other immigrant studies showed 
comparable results 3. The incidence of colon cancer also varies 
amongst groups with different life styles within one population. For 
example there is a much lower incidence amoung Seventh Day 
Adventists, who consume a strict vegetarian diet, compared to the 
rest of the American population 4. The observation that Africans, con-
suming a high amount of dietary fiber, have a low large bowel 
incidence rate, caused Burkitt to speculate that fiber could have a 
protective effect on colon cancer 5. Since then, several epidemiologi-
cal and case-control studies have been carried out, most of them 
supporting the fiber theory e'7. Controversy exists about different 
protective effects of fiber from vegetables or from cereals. In a large 
meta-analysis of 13 case-control studies, an odds ratio of 0.58 was 
calculated for high versus low fiber intake and of 0.48 for high versus 
low vegetable consumption 8. In this meta-analysis, seven out of 13 
studies strongly supported for the fiber hypothesis, two gave 
moderate and two gave an equivocal support. There are few large 
scale prospective studies examing the relationship between dietary 
fiber consumption and large bowel cancer risk. The Nurses' Health 
Study, a prospective study of more than 80.000 American nurses, 
has shown that the group with the highest animal fat and the lowest 
crude fiber intake had the highest risk for large bowel cancer. 
However, the effect of a high fat consumption was more significant 
than the low fiber intake 9. Recently, another prospective study has 
found a strong negative correlation between fiber consumption and 
colonic adenomas with a relative risk of 0.36 in the high fiber group10. 
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Interestingly in familial adenomatous polyposis patients, who have a 
high risk of developing colonic cancer, supplementation of the diet 
with wheat bran significantly reduced the number of polyps in the 
remaining rectum after ¡leorectal anastomosis Ί Ί. 
Finally, the protective effect of dietary fiber was recently supported 
by Cummings et al, who demonstrated a significant correlation 
between dietary fiber intake and stool weight, and an inverse 
relationship between stool weight and colorectal cancer incidence in 
20 different populations 12. 
In conclusion, there is a growing body of support for the protective 
effect of dietary fiber against the risk of colonic cancer. 
Mechanisms for the protection of fiber on colonic 
carcinogenesis. 
Several mechanisms have been proposed to explain the protective 
effect of dietary fiber. As it is not digested in the small intestine, it 
will enter the caecum and be partly fermented by colonic anaerobic 
bacteria. This results in the production of gas (hydrogen, methane, 
and C02) and short chain fatty acids (SCFA's), notably acetate, 
propionate, and butyrate. SCFA's are an important source of energy 
for these bacteria and thus the bacterial mass increases 13,14. Only a 
small proportion of fiber from cereals is fermented, but the remaining 
carbohydrates can absorb water and contribute to fecal bulking. The 
increase in fecal mass due to bacterial growth and residual compo­
nents of fiber results in a dilution of the contents of the large bowel, 
and therefore lowers concentrations of putative (co-)carcinogens like 
faecopentaenes, heterocyclic amines and secondary bile acids. 
Furthermore, fecal bulking results in a decreased colonic transit, 
reducing the exposure time to irritants and (co-)car-cinogens. 
Secondly, SCFA production will lower the colonic pH. A more acid 
colonic environment might be associated with a lower colon cancer 
risk 15,1β. Some studies have shown that decreasing the colonic pH 
has a protective effect against experimentally induced colon cancer 
17
, although others have reported conflicting results 18. The means by 
which an acid colonic environment protects against carcinogenesis is 
not fully understood, but it is probable that precipitation of bile acids 
and inhibition of the formation of secondary bile acids play an 
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important part in this process. 
Finally, it has been suggested that butyrate, one of the SCFA's 
produced by fermentation, can exert a direct protective effect on the 
colonic mucosa 19. 
The role of bile acids and SCFA's will be discussed extensively. 
Fermentable substrate. 
The relation between fiber, fermentation, and the prevention of colon 
cancer has been the subject of extensive research. One of the 
problems in interpreting the results is, that fiber is the collective term 
for a number of food components, all having individual physical and 
chemical properties 20~23. Fiber is defined as that part of the plant wall 
matrix, which cannot be broken down by human enzymes. It includes 
all ηοη-σ-glucan polymers. The most important components of dietary 
fiber are cellulose, hemicellulose, pectin and lignin. They are fermen­
table to differing degrees, pectin being an example of a readily 
fermentable substrate and lignin an inert material 2 4 2 e . Furthermore, 
dietary fiber is not normally consumed alone but as part of grains, 
vegetables and fruits. The ways in which these food products are 
processed, and the particle size of fiber also affect fermentability. The 
different properties of fiber components probably contribute largely to 
the controversy to its role in colonic cancer prevention. 
Besides fiber, several other sources of fermentable substrate have 
been identified; the most important being the starch (and its degrada­
tion products) that escapes small bowel digestion. This so called 
'resistant starch' has recently become an interesting area of research. 
Other substrates for cecal fermentation are proteins, glycoprotein and 
mucopolysaccharides 2 7, but these are quantatively less relevant. The 
daily amount of protein that reaches the large bowel is equivalent to 
only 1-2 g nitrogen 2 8. During rapid fermentation, branched SCFA's 
are also produced (iso-butyrate and iso-valerate) 29,3°. In subjects with 
carbohydrate malabsorption (e.g. subjects with lactase deficiency), 
fermentation is further stimulated by the additional load of unabsor-
bed carbohydrates 31. 
In conclusion, the diet contains a wide variety of potential substrates 
for fermentation but current findings would suggest the most impor­
tant are resistant starch, fiber, and to a lesser extent protein. 
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Resistant Starch. 
During the last decade, it has been observed that not all ingested 
starch is absorbed in the small bowel 2 7 '3 2 3 5. This fraction of non-
absorbed starch is called resistant starch. The name was originally 
introduced by Englyst and Cummings э for retrograded amylose, but 
now the term has expanded and the definition for resistant starch is 
the fraction of starch and starch degradation products that are not 
absorbed in the small bowel of healthy subjects. Starch can be 
classified as readily digestible starch, slowly (but completely) 
digestible starch and resistant starch, depending on the physical form 
and the susceptibility to human σ-amylase. Three different subgroups 
of resistant starch can be distinguished: type I or physically inaccessi­
ble starch (e.g. partly milled grains); type II or starch in granules (e.g. 
raw potato and bananas); type III or retrograded starch (e.g. cooked 
and cooled potatoes, old bread). 
In a normal western diet, about 10% of ingested starch escapes small 
bowel absorption and will enter the colon 35. The amount of resistant 
starch in food products depends on cooking and processing. Raw 
potato starch consists of 75% resistant starch 37. In freshly cooked 
and warm potatoes, only 3% of starch is still resistant but after 
cooling the resistant starch fraction increases to 12% 3β. This is 
probably related to changes in the three-dimensional molecular struc­
ture of the starch chains; starch in highly crystallized form being 
generally resistant to mammalian σ-amylase. Colonic bacterial 
enzymes however, can degrade this resistant starch completely 3 9. In 
contrast to most fiber components, starch is completely fermented in 
the large bowel and that is why starch is probably the primary of 
fermentable substrate 27,35. The hypothesis that starch can have a 
protective effect on colonic carcinogenesis is supported by a study of 
Thornton et al, in which it has been demonstrated that starch fermen­
tation in colonic adenoma-patients is relatively low compared to 
controls 4 0. 
It is concluded that a significant amount of starch is fermented in the 
large bowel, and that it is an important source for short chain fatty 
acid production. 
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The relation between colonic pH and large bowel cancer. 
The production of short chain fatty acids during the fermentation 
process results in a decrease of the intraluminal pH 4 1. This could 
have implications for colonic carcinogenesis, as several epidemiologi­
cal studies have supported a lower colon cancer risk with lower fecal 
pH. In India, railway workers with a fecal pH below 6 had a lower 
colon cancer risk, while a high incidence was found in persons with a 
fecal pH of 8 or more 42. In African ethnic populations, a low colon 
cancer risk has been associated with a low fecal pH 1θ, and in 
American Seventh Day Adventists, who are known to have a low 
colon cancer risk, the fecal pH is significantly reduced compared to 
controls and colon cancer patients 43. Although not supported by all 
case control studies 4 \ most authors agree on the protective effect of 
a low colonic pH on large bowel carcinogenesis. It is possible to 
decrease the colonic pH to a variable extent by dietary manipulation, 
by using fibers such as oat bran, wheat bran and cellulose 1 β · 2 0 ' 4 5 - 4 7 or 
by supplementation of lactulose 48"51; although not all studies demon­
strate a change of fecal pH after fiber or lactulose supplementation. 
We speculate that this controversy is related to the fact that fecal pH 
is a poor indicator of acidity in the proximal colon. Cummings et al 
demonstrated that in humans the mean caecal pH of 5.6 gradually 
rose to 6.6 in the descending colon 4 1, these results were confirmed 
using a radiotelemetry pH-device 52. The observed change in pH along 
the colon is due to the buffering capacity of the luminal contents, and 
to the rapid absorption of SCFA's during their transport from caecum 
to descending colon 2 0·5 3·5 4. Thus fecal pH is not necessarily a good 
indicator of fermentation and acidity in the proximal colon. 
The influence of colonic pH on bile acid metabolism. 
In 1981 it was proposed by Thornton that a high colonic pH promotes 
co-carcinogen formation from bile acids, and that acidification of the 
colonic contents by SCFA formation may prevent this 15. Bile acids, 
especially secondary bile acids, are irritating to the colonic epithelium 
and several experiments have shown a co-carcinogenic effect (see 
below). Conjugated primary bile acids, produced in the liver and 
excreted in bile, are largely (90%) absorbed in the small bowel, the 
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remaining 10% being transported into the colon. Bacterial enzymes 
deconjugate these bile acids very rapidly, and anaerobic bacteria, 
producing 7a-dehydroxylase, convert primary bile acids into the 
secondary bile acids deoxycholic acid and lithocholic acid 55,5e. The 
7a-dehydroxylase-enzymes are pH dependent, with an optimum at pH 
7-8, and are inactivated at pH below 5.5 " . In a fecal incubation 
system, we have demonstrated a complete conversion of the primary 
bile acids, cholic acid and chenodeoxycholic acid (1 mmol/l), into 
deoxycholic acid and lithocholic acid respectively, during an 24 hour 
incubation at ph = 6.0 (fig. 1 A). Decreasing the pH to 5.0, resulted in 
complete inhibition of the bacterial conversion (fig 1B). 
Precipitation of bile acids is the alternative mechanism by which their 
interaction with colonic mucosa may be prevented. Soluble unconju-
gated bile acids have pK„'s of around 5.0 58 and if the pH decreases 
below this as a result of fermentation, precipitation is possible. As 
only the soluble bile acids are able to affect the mucosal cells, a shift 
from the aqueous phase of stool to the insoluble compartment will 
result in a decrease in their putative damaging effect 59. Indeed, in a 
rat model, the toxic effect of deoxycholic acid to the colonic mucosa 
was prevented by decreasing the pH from 7.9 to 5.5 eo. 
INCUBATION TIME (HR) 
- · - CA · DCA 
INCUBATION TIME (HR) 
· - CDCA » LCA 
Figure 1: Conversion of primary bile acids in a fecal incubation system at pH = 6.0 
(A) and at pH=5.0 IB}. Bile acids were determined by gas chromatography in 
freeze-dried material ( CA: Cholic acid; DCA: Deoxycholic acid; CDCA: Cheno-
deoxycholic acid; LCA: Lithocholic acid). 
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It can be concluded that the protective effect of decreased luminal pH 
on colon cancer incidence is at least partly mediated by the inhibition 
of formation of bile acids or by their precipitation. 
The role of bile acids in colonic carcinogenesis. 
In 1969, Aries and Hill proposed that colon cancer was caused by 
bacterial conversion of bile acids into a carcinogenic metabolite in the 
gut β 1, but to date these specific metabolites have not been found. 
However, several animal experiments have demonstrated that 
secondary bile acids have a promoting effect on large bowel carcin­
ogenesis. In experiments with rats, rectal infusion of the secondary 
bile acids deoxycholic acid and lithocholic acid in rats has been 
shown to stimulate experimentally-induced carcinogenesis " . 
Similarly, increasing the fecal bile acid concentration by feeding bile 
acids or cholestyramine, or by diversion of the bile duct to open into 
the caecum, has also demonstrated an enhancement of mucosal 
damage and the number of experimentally-induced colorectal tumours 
in rats β 3 β \ Bile acids given intrarectally without chemical carcinogens 
did not result in tumor formation, suggesting bile acids themselves 
act as promoter or co-carcinogen but not as real carcinogen. Co-
mutagenicity has also been demonstrated in vitro for secondary bile 
acids using the Ames Salmonella mutation test 6 5 . 
Although there is much evidence from animal experiments to support 
the influence of bile acids on colonic carcinogenesis, their effect in 
humans is still not proven. Several epidemiological studies have been 
carried out, comparing the fecal bile acid concentration in high and 
low risk populations. Most of these population studies have demon­
strated a positive correlation between fecal bile acid concentration 
and colon cancer risk, however case control studies have provided 
conflicting results βθ'97. We suggest that the discrepancy between 
these studies is partly related to the fact that only total bile acid 
concentrations were measured. It should be stressed that most of the 
fecal bile acids are precipitated or bound to luminal residues, leaving 
less than 1 % in solution, and thus available for interaction with 
mucosal cells (unpublished results). Only recently has emphasis been 
placed on the bile acid concentration in the aqueous phase of stool, 
rather than the total concentration 5 9 θ 0 . 
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Serum bile acid concentrations are a reflection of the soluble fraction 
in the gut lumen and are therefore perhaps a better indicator of risk 
than total fecal concentrations. Van der Werf et al have demonstrated 
an increased deoxvcholic acid absorption in patients with colonic 
adenomas β β, and very recently a consistently elevated level of serum 
deoxycholic acid has been found in patients with colonic adenomas 
θ9
. We conclude that, altogether there is substantial evidence 
supporting the promoting effect of secondary bile acids on colonic 
carcinogenesis. 
Cytotoxicity, hyperproliferation and tumor promotion of 
bile acids. 
Damaging effects of various bile acids on the colonic mucosa have 
been described at the concentrations present in the aqueous phase of 
stool. Bile acids can disrupt the integrity of the cell membrane of 
colonic mucosal cells β 0·β 4·7 0'7 1. The increased cell loss will stimulates 
a compensatory cell renewal by increased mucosal proliferation. 
Thus, dietary manipulation resulting in a rise in colonic bile acid 
concentration causes increased mucosal proliferation 71,72. Surgical 
diversion of bile, eliminating bile acids in the colon has also been 
shown to reduce colonic proliferation " . In addition to the attractive 
hypothesis that hyperproliferation is induced by the cytotoxic poten­
tial of bile acids, there is also evidence of a direct stimulatory effect 
of several bile acids on proliferation, probably mediated by Protein 
Kinase С activation in the colonic cell 74,75. Protein Kinase С appears 
to play a critical role in tumor promotion and in the action of growth 
factors 7Θ. 
The bile acid induced increase in mucosal proliferation may be the key 
step in the association between bile acids and colon carcinogenesis. It 
has been demonstrated that a hyperproliferative colonic mucosa is 
more susceptible to carcinogens than a quiescent mucosa 7 7 7 Э . When 
proliferation is increased, the fraction of cells in S-phase ('target-
cells') is relatively high, possibly resulting in an increased potency of 
intraluminal mutagenic substances. 
Large bowel neoplasms are associated with changes in proliferative 
characteristics and in patients with colonic carcinomas, an overall 
increased colonic mucosal proliferation has been demonstrated 8 0. 
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Furthermore, the proliferative compartment expands from the basal 
part of the crypts to the luminal surface 81. Similar changes in 
proliferative activity can be seen in patients with familial adenom­
atous polyposis, who are at high risk of developing colonic cancer B2. 
The relationship between hyperproliferation and colorectal cancer has 
led to the use of mucosal proliferation as an established intermediate 
biomarker in assessing colon cancer risk. In this respect, it is interest­
ing that dietary wheat bran supplementation has been demonstrated 
to decrease rectal proliferation in high risk patients with previously 
resected large bowel cancer 83. 
In conclusion, the tumor promoting effects of bile acids may be 
mediated by a direct effect or by their cytotoxic potential and the 
compensatory epithelial hyperproliferation, leading to a increased 
effect of mutagenic substances. 
The effect of butyrate on cellular differentiation and 
proliferation. 
One of the SCFA's produced by fermentation is butyrate. It is an 
important factor in the metabolic welfare of the colonic epithelium, 
and it is the primary energy source for the mucosal cells 8 4 , 8 5. Besides 
influencing intraluminal pH (as do other SCFA's), butyrate is purpor­
ted to have typical antineoplastic effects. Several experiments have 
demonstrated that butyrate can induce differentiation in cultured 
human colonic adenocarcinoma cells θ β 8 β . Furthermore, butyrate can 
reduce the growth characteristics of human colonic cancer cell-lines 
8 6 , 8 9
 and human colonic mucosal cells in vitro 19 and in vivo 90. 
Butyrate derivatives are currently being studied for anti-neoplastic 
activity 8 1. It has been speculated that this regulatory effect is 
mediated by an inhibition of histone deacetylase and phosphorylation 
87
, but the exact mechanism is still unclear. In contrast, an increase in 
mucosal proliferation has also been demonstrated by butyrate 9 2. But 
as it is a major energy-source for the large bowel mucosa, prolifer­
ation may be stimulated in certain circumstances by this trophic 
potential. 
The potential beneficial effect of butyrate has been supported by data 
from case control studies, in which a low fecal butyrate concentration 
has been found in patients with colonic adenomas, compared to 
Fermentation and colon cancer prevention 25 
controls 4 7 , 9 3. Another study demonstrated a decreased production of 
butyrate during fiber fermentation in patients with colonic cancer or 
adenomas 9 4. 
If butyrate does have anti-neoplastic potential, consumption of 
resistant starch is of particular interest, as fermentation of starch 
yields twice the amount of butyrate in the colonic SCFA-pool2Θ'27. 
Conclusion. 
There is a growing body of evidence that fermentation of fiber and 
especially resistant starch, has a protective effect on large bowel 
cancer. In figure 2, we describe the possible mechanisms of this 
protection. The production of short chain fatty acids decreases the 
colonic pH, which is probably followed by precipitation of primary and 
secondary bile acids. 
FAT FIBRE RESISTANT GENETICAL 
STARCH FACTORS 
U 
i 
BUTYRIC ACID 
PROPIONIC ACID 
ACETIC ACID 
i 
NORM. MUCOSA 
' i 
SMALL ADENOMA 
I 
CYTOTOXICITY · - > HYPERPROLIFERATION 
ρΗψ 
"i 
PRIM. BILE ACIDS - > SEC. BILE ACIDS « 
i 
LARGE ADENOMA 
1 
CANCER 
Figure 2: Hypothesis of the influence of fermentation on large bowel carcinogene­
sis. 
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When bile acids are precipitated, their interaction with the colonic 
mucosa is inhibited. Furthermore, the activity of bacterial 7a-dehy-
droxylase (needed for the conversion of primary into secondary bile 
acids) is inhibited by an acid environment. Bile acids, especially the 
secondary bile acid deoxycholic acid, can stimulate colonic mucosal 
proliferation either directly or mediated by membrane damage. 
Precipitation of bile acids, or inhibition of the formation of secondary 
bile acids can inhibit this effect. It's relevance in colonic carcinogene-
sis is linked to hyperproliferation being a proposed initial stage in the 
transformation of normal mucosa into cancerous tissue. The short 
chain fatty acid, butyrate, also appears to play a role in the regulation 
of the mucosal proliferation, by a direct inhibitory effect. 
Although some of these mechanisms are still the subject of debate, 
we believe that potent stimulation of colonic fermentation, using a 
substrate such as resistant starch, may play an important role in the 
prevention of large bowel cancer. 
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Introduction. 
A great deal of the interest of the effects of dietary fiber on bile acid 
metabolism is derived from the interrelationship between diet and 
cholesterol metabolism, and from the role of nutrition in the 
development of colorectal cancer. In this review the relation between 
dietary fiber and bile acid metabolism is focused around their role in 
the development of colorectal cancer. 
Bile acids are the major end products of cholesterol metabolism and 
synthesized in the liver. The primary bile acids cholic acid (CA) and 
chenodeoxycholic acid (CDCA) are derived via several intermediate 
steps from cholesterol and secreted in bile as glycine or taurine 
conjugates. They serve as cholesterol solubilizing agents by the 
formation of micelles and play an important role in the digestion and 
absorption of lipids in the small intestine. More than 95 % of the bile 
acids passing the ileum are reabsorbed and return to the liver through 
the portal vein. An efficient conservation in the so- called 
enterohepatic circulation is thus achieved. The proportion of bile acids 
not absorbed in the terminal ileum is 2-5% per cycle and amounts to 
an average loss of 20% of the bile acid pool with 6-12 enterohepatic 
circulations per day. Bile acids that escape absorption in the ileum, 
are metabolized in the large bowel by the anaerobic bacterial flora. 
First, deconjugation takes place and the amino acid molecule on the 
carboxyl group is removed. Secondly, the primary bile acids CA and 
CDCA are dehydroxylated and converted into the secondary bile acids 
deoxycholic acid (DCA) and lithocholic acid (LCA) respectively. 
Further bacterial degradation in the large bowel and alterations in the 
liver produce the tertiary bile acids (figure 1). DCA is partly absorbed 
in the colon and enters the enterohepatic circulation, where it is 
conjugated in the liver and secreted in bile; LCA is almost insoluble 
and very little is reabsorbed. Both secondary bile acids are excreted in 
the stool and make up to 95 % of the total amount of excreted bile 
acids. In the stool the major part of the bile acids are bound to dietary 
and bacterial residues. In the circulating bile acid pool, CA and CDCA 
each comprise about 30-40%, DCA about 20-30% and LCA for less 
than 5% of the total amount1'2. 
It is postulated that secondary bile acids play a promoting role in 
colonic carcinogenesis 3e. According to the hypothesis, these bile 
acids damage the colonic epithelium, causing hyperproliferation in the 
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Figure 1: Pathway of primary, secondary and tertiary bile acid synthesis. 
colonic crypts, which than leads to an increased risk of malignant 
degeneration. Of course this is an simplification of reality, since it is 
well known that many other factors are involved, especially genetic, 
hormonal and growth factors. 
The influence of dietary factors on colonic carcinogenesis. 
The incidence of colorectal cancer is high in Western countries and is 
related to dietary habits. Currently it is assumed that dietary factors 
modulate a genetic susceptibility. In epidemiological observations the 
consumption of animal fat is positively related to the incidence of 
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colon cancer. The intake of fiber is possibly negatively related to this 
incidence, however, many inconsistencies exist. In a recently 
published meta-analysis 7 of observational epidemiological and of 
case-control studies, a protective effect of dietary fiber on the 
occurrence of colonic cancer was found in most, but not all studies. 
The overall odds ratio for the high fiber groups in the case-control 
studies was 0.57 (CI 0.50-0.67). One thing that has to be kept in 
mind is the often reciprocal relation between fat and fiber intake. An 
increase in fiber intake will easily lead to a decrease in fat intake or to 
a change in the total energy intake. An interesting substance that 
recently has drawn more attention is "resistant starch", defined as 
starch that can not be absorbed in the small bowel. This resistant 
starch is supposed to have effects on the large bowel, comparable 
with fiber. Besides the influence of fiber (resistant starch), fat and 
total energy intake other dietary constituents like trace elements and 
vitamins have been suggested to play a more or less important role. 
There are several possible explanations for the protective effect of 
fiber. The most consistent are: 
The stool-bulking effect, leading to a decrease in concentration of 
potentially carcinogenic substances, the acceleration of gut transit 
time, the binding of bile acids, and the fermentation of parts of fiber 
and probably most of the starch to short chain fatty acids (especially 
butyrate, which has antineoplastic properties in vitro). The short chain 
fatty acids will lower the pH and this causes a decrease of activity of 
the enzyme 7o-dehydroxylase, leading to a reduction of the 
formation of secondary bile acids. Moreover, because of the more 
acidic environment, bile acids may be precipitated. Fiber and resistant 
starch are supposed to alter the bacterial flora in the colon, leading to 
a decrease in -possible carcinogenic- nitrogen-containing substances. 
The hypothesis postulates that a high fat diet enhances the formation 
and degradation of bile acids and neutral sterols and that these 
compounds exert a promoting effect in colonic carcinogenesis 5. 
Indeed, it has been found that dietary fat increases the output and 
fecal concentration of bile acids , 0 1 2 and epidemiological evidence has 
shown that populations with a high incidence of colorectal cancer, 
consuming a high fat and animal protein diet, excrete about twice the 
amount of secondary bile acids 1Э. The concentration of these bile 
acids was also increased. However, other studies in the United 
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States, Great Britain and New Zealand have failed to demonstrate a 
correlation between a high fat intake and colorectal cancer incidence 
14,15
. Case-control studies have shown conflicting results in this 
respect 1 Θ 1 ? . 
Studies about dietary fiber and bile acid metabolism. 
Dietary fiber is that part of the plant wall matrix which can not be 
broken down by human enzymes. The most important resources are 
wheat, vegetables and fruit. 
The most important components of fiber are: cellulose, hemicellulose, 
pectin and lignin. Different components can exert several 
physiological effects, which depend on processing, particle size, the 
source of fiber, and the individual characteristics of the consumer, 
like transit time and colonic microflora. Since animals often have a 
very different bile acid pattern, only human studies will be reviewed 
in this manuscript. 
In many of the published studies the main goal was not the effect of 
fiber or parts of fiber on bile acid metabolism, but to investigate the 
role of fiber on cholesterol metabolism. This was based on the 
hypothesis that by increasing the excretion of acidic (bile acids) 
sterols and neutral sterols through the consumption of dietary fiber, 
the serum cholesterol level could be lowered. Other studies with 
regard to the effect of dietary fiber on biliary bile acids were initiated, 
because of the hypothesis that fiber may decrease the cholesterol 
saturation index (CSI) of bile, which is a major factor in the 
development of gallbladder bile stones. Since deoxycholic acid may 
increase the CSI, many investigations concentrated on the effect of 
fiber (or fiber components) on individual biliary bile acids. 
Pitfalls in the interpretation of dietary fiber studies. 
In studies concerning the effect of dietary fiber on bile acid 
metabolism, different types or components of fiber were used. As 
mentioned above, this can lead to different and sometimes conflicting 
results. 
The age and gender of the subjects in the different studies were often 
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not comparable. It is well known that DCA metabolism is age-
dependent 18. Elderly persons have a higher DCA content in bile than 
younger persons e. 
In several of the studies, the subjects had gallstones or a high 
cholesterol saturation index. These patients mostly have a higher 
DCA content, and differences caused by dietary intervention are more 
likely to occur. Many studies were carried out in hyperlipidemic 
patients; the close interrelationship between cholesterol and bile acids 
could have biased the data. 
In the dietary intervention studies, the relation with other dietary 
factors like fat and total energy intake is important when looking at 
the changes in bile acid metabolism. In most of the studies the intake 
of other food items (like fat) was not controlled for. It is conceivable 
that even motivated volunteers who have to consume 30 gram bran 
per day will lower their fat intake. This can have profound 
consequences on bile acid metabolism. 
The duration of the dietary intervention may influence the effect on 
bile acid metabolism. The length of the different investigations varied 
from 4 days to one year, but in most studies the effect of fiber was 
investigated for 3-6 weeks. From the results in several investigations 
it is clear that the effect of fiber on colonic function and bile acid 
metabolism takes some time to occur. Otherwise, some experimental 
data suggest an adaptation after a longer period of fiber 
administration, leading to a reversion of the initial changes. We 
studied the influence of a low fiber diet, followed by a 10 week diet 
with a high content of mixed natural fiber. We found a decrease in 
biliary DCA of 15% and a increase of CA of 24% after 6 weeks high 
fiber diet, but a return to basal values after 10 weeks 19. 
No clear understanding exists at this moment whether long-term 
administration of a natural high fiber diet can induce changes in bile 
acid metabolism that would benefit patients at risk of developing 
colon cancer. 
Different endpoints in dietary intervention studies. 
Changes in serum bile acid concentrations or biliary bile acid 
composition are of less interest concerning the potentially protective 
effect of fiber on colonic cancer because they only reflect indirect 
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changes in the colonic environment. 
The total fecal output of bile acids, mostly secondary bile acids, has 
been used as an endpoint in several fiber studies. This is probably for 
the most part correlated to changes in colonic bile acid metabolism, 
but most of the bile acids are bound to fiber and bacteria and thus not 
really in interaction with the colonic mucosa. 
Perhaps kinetic studies involving the DCA pool size and especially the 
DCA input rate are a more useful endpoint. The DCA input rate and 
the unconjugated DCA fraction in serum tells us something about the 
newly formed and absorbed DCA. This is, in fact, the DCA fraction 
that is in close contact with the mucosal cells. Unfortunately, only 
very few studies concerning this matter have been carried out. 
Probably the most useful endpoint in fiber studies is the DCA 
concentration in the aqueous phase of stool. This can give us the 
most direct information about the micro-environment of the colonic 
mucosa, that is the place of interaction between secondary bile acids 
and colonocytes. We will discuss the different fiber studies, looking 
at the different endpoints described above. 
Dietary fiber and biliary bile acids. 
In figure 2, a number of studies is shown, in which the effect of 
wheat bran or natural fiber on the biliary bile acid pattern has been 
examined. 
In most studies 30-60 gram of bran per day was used as a fiber 
source. These amounts are equivalent to 11-22 gram of dietary fiber. 
The overall effect was a moderate (13-49%) decline in DCA content. 
Sometimes a concomitant rise in CDCA content in bile was found. 
Tarpila et al 20 and Marcus and Heaton 21, however, detected that a 
fall in DCA was accompanied by a rise in the CA percentage in bile, 
while the CDCA fraction remained constant. The same holds true for 
the study of Thornton 22, which was the only one that used dietary 
fiber from several sources like cereals, vegetables and fruit. We have 
recently completed a control-led study with a natural high fiber diet 
and came to the same results 19. 
A hypothesis concerning the reciprocal relationship between DCA and 
CDCA has been put forward by Pomare et al 23, assuming that DCA 
inhibits the synthesis of CDCA in the liver. 
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Figure 2: Changes in biliary bile acid composition in studies using wheat bran or a 
natura/ high fiber diet. 
Some controversy about this hypothesis however, still exists. Of 
course, the decrease in the percentage of biliary DCA will lead to an 
obligatory increase in the percentage of the other bile acids. 
In figure 3, studies are shown, in which the effect of different 
components of fiber and of lactulose, a non-absorbable, fermentable 
disaccharide, was examined. It is striking that in 2 studies in which 
pectin was used, an increase in biliary DCA was found 24,2S. The 
explanation is not clear, but perhaps this controversial result is 
caused by one of the physico-chemical properties of pectin. Pectin is 
a strong gelformer in the jejunum, which can bind primary bile acids 
and thus prevent their absorption. In the colon, pectin will be 
fermented and the liberated primary bile acid will be dehydroxylated 
to secondary bile acids, which can explain the increase in DCA 
content. The effects of cellulose and lactulose are comparable to the 
effects of wheat bran and natural fiber. 
The reduction of the DCA content in bile could be explained by 
several mechanisms, which have been reviewed by Heaton 2e. 
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Figure 3: Changes in biliary bile acid composition in studies using pectin, cellulose 
or lactulose. 
Theoretically, the most likely explanations are: 
1. By the adsorption of newly formed DCA in the large bowel to 
dietary fiber, which has been shown in vitro to occur more 
strongly for DCA than for the other bile acids 27. Also bacteria 
that feed and multiply on bran are capable of binding bile acids. 
2. By the acceleration of the transit of colonic contents. This would 
decrease the absorption of DCA. This effect has also been 
shown to occur with laxatives. However, Marcus and Heaton 28 
found no correlation between changes in transit time and 
alterations in DCA pool sizes or percentages. 
3. By the bacterial fermentation of fiber components, which can 
give rise to the formation of short chain fatty acids and results in 
a reduction of the intraluminal pH. Such an effect has been 
found after administration of lactulose, a non-absorbable 
disaccharide, which is completely fermented in the large bowel 
and can decrease the DCA content in bile as has been shown by 
several authors e-29'30. Lowering the pH would inhibit bacterial 
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7o-dehydroxylase and thus reduce the formation of the 
secondary bile acids DCA and LCA. Acidification of colonic 
contents might also limit the absorption of DCA by precipitation, 
because DCA is poorly soluble at low pH. 
In summary, dietary fiber can exert effects on secondary bile acid 
metabolism,which seem largely dependent on the type and source of 
fiber. Whether in the long run, a natural high fiber diet really can 
lower the level of circulating secondary bile acids remains to be seen. 
Dietary fiber and fecal bile acids. 
In figure 4 a review of a number of studies is shown concerning the 
effect of wheat bran on the concentration and excretion of fecal bile 
acids. In figure 5 the overall results of the studies using other types 
of fiber are depicted. 
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Figure 4: Changes in fecal bile acid excretion and concentration in studies using 
wheat bran. 
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It is hypothysed that secondary bile acids will damage the colonic 
epithelium, causing a hyperproliferation in the colonic crypts. 
Assuming the hypothesis is correct, than only soluble bile acids 
should exert the irritative effect on the colonic mucosa. However, in 
all studies concerning the effect of fiber on fecal bile acids, the total 
concentration based on stool dry weight or total excretion is given. 
The concentration of bile acids in fecal water is normally relatively 
low. From figure 4 it can be seen that consumption of wheat bran 
generally increases the daily output (excretion) and decreases the 
concentration of fecal bile acids. In almost all studies fecal weight 
increased, giving the most likely explanation of the result of 
decreased concentration and increased excretion. 
As shown in figure 5, the results of studies using other types of fiber 
are less consistent. The suppletion with natural fiber has the same 
effect as administering wheat bran. The importance of the source of 
fiber is illustrated in two studies with oat bran. Oat bran has almost 
no effect on the concentration of fecal bile acids, while the excretion 
increased 3 2. An explanation could be the fact that oat bran contains 
much less cellulose than wheat bran. Cellulose has been shown to 
decrease the concentration of fecal bile acids э з. Pectin in rather small 
quantities (10-15 gram) can increase bile acid excretion 2 4 , 3 4 and 
concentration. The source of pectin is important in this respect, as is 
shown in the study of Stasse-Wolthuis35. Ten gram of pure pectin 
increased the excretion, but the same dose derived from vegetables 
and fruit had no effect. 
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Figure 5. Effect of different fiber components on fecal bile acids. 
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It is remarkable that in three studies with doses of 33-60 gram fiber 
from different natural sources (corn, vegetables and fruit) no effect 
could be detected З Э8 while we found a decrease in the 
concentration after suppletion with 15 gram natural fiber 19. It is 
conceivable that various components of dietary fiber can have 
opposite effects, resulting in a net neutral effect. Another reason for 
differences between the results obtained by several studies are age 
and gender of the subjects. It has been shown that age dependent 
differences exist in the concentration of fecal bile acids 2. In the 
reported studies age varied from 20-80 years. Gender could also 
influence results. In many studies only men or women were 
investigated. Stasse-Wolthuis 37 found a sex difference in secondary 
bile acid excretion (increase in women, decrease in man), but had no 
valid explanation for this observation. 
A factor that was not accounted for in many studies was the previous 
nutritional status and consumption pattern of the volunteers. 
Especially the intake of fiber, fat and cholesterol is important, 
because these nutrients have profound implications on the baseline 
concentration and excretion of bile acids. 
In subjects consuming lactulose it has been shown that the 
dehydroxylation of primary bile acids can be inhibited, thereby 
increasing the concentration of these compounds and decreasing the 
level of secondary fecal bile acids e,3°. Fermentation of lactulose in 
short chain fatty acids leading to a decline in colonic pH, is largely 
responsible for this effect. Despite the fact that parts of dietary fiber 
can also be fermented into short chain fatty acids, studies that have 
looked at individual bile acids did not find a significant increase in 
primary bile acid concentration. In fact more than 95% of the fecal 
bile acids on a high fiber diet consisted of the secondary bile acids 
DCA and LCA. This difference is probably caused by a slow and 
incomplete fermentation process of fiber. 
Dietary fiber and DCA kinetics. 
Surprisingly few studies have looked upon the effect of fiber or its 
components on the kinetic parameters of bile acid metabolism. 
Hoffmann39 and Stellaard 40 have demonstrated the complexity of the 
formation, absorption en enterohepatic circulation of secondary bile 
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acids. The only way to get a reliable insight into the dynamics of bile 
acid metabolism is to perform kinetic experiments using radio-active 
or stable isotopes. However, the availability of this technics is limited 
and radio-active isotopes can not be used in experiments with healthy 
volunteers in most countries. Previously, we demonstrated an 
increased level of DCA input in patients with colonic adenomas, 
compared to healthy controls 41. 
It must be kept in mind that 7a-dehydroxylation is an age-dependent 
process. Elderly persons have a higher DCA input rate than younger 
people 1B. 
Data about the influence of transit time on DCA pool size and DCA 
input are rather conflicting. Marcus and Heaton found an increased 
DCA pool size in persons with prolonged transit time in one study 2 8, 
but in contrast, three other studies did not show any relation 1 θ · 2 1 ' 3 0 . 
In fiber supplementation studies, using kinetic experiments, different 
results were found. Pomare 2 3 , 4 2 demonstrated that bran reduces the 
circulating DCA pool and another study showed the same for cereals 
4 3
. After lactulose ingestion, both the DCA pool size and DCA input 
decreased, although only the DCA pool size changed significant30. 
In contrast, three other studies 21·22·44 with bran and natural fiber did 
not show any changes in DCA pool size. 
Huybregts 4 4 found a small increase in the DCA input in the circulating 
pool after wheat bran supplementation. It must be remembered that 
the 4 healthy subjects in the last study were already consuming a 
high fiber diet and had small DCA pools to begin with. DCA input 
increased significantly after 8 weeks, but not after 4 weeks. 
In two other studies no significant changes in DCA input where 
detected 21 " . 
Dietary fiber and DCA in the aqueous phase of stool. 
Several reports have indicated that the DCA concentration in fecal 
water is of more relevance concerning the risk of colonic cancer than 
is the total fecal bile acid concentration 45"49. This can be explained in 
theory by the fact that the DCA concentration in fecal water 
expresses the DCA fraction that is in contact with the mucosal cells. 
Stadler demonstrated 4 9 a significant higher DCA concentration in 
fecal water in patients with adenomatous polyps or colon cancer, 
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compared to patients without colonic pathology. Geltner 47 showed 
that a shift from a mixed to a lactovegetarian diet, leading to a 
decrease in fat intake and an increase in fiber intake, resulted in a 
significant decrease of the DCA concentration in fecal water from 
125 to 75 /лпоІ/І, but not in a change in total bile acid concentration 
in feces. Also, the cellular toxicity -measured by incubating fecal 
water with erythrocytes and detecting the lysis of these cells- of the 
aqueous phase of stool decreased. Although data about bile acid 
concentrations in fecal water are rather scarce, it is a promising 
parameter in studying bile acid metabolism in relation to colonic 
cancer. 
Conclusions. 
From the reviewed literature it is clear that dietary fiber has an 
influence upon bile acid metabolism. There is also evidence that a 
high fiber intake is related with a lower incidence of colonic cancer. 
However, it is not yet prooven wether this decline in risk is caused by 
changes in the bile acid metabolism, due to the high fiber diet. In this 
respect the lower fat intake that goes along with an increase in fiber 
consumption could have biased the results. One of the problems in 
determining the exact influence of fiber on bile acid metabolism is 
that different components of fiber or fiber degradation products have 
all their own different physiochemical properties, that can even act 
controversial. Dietary intervention studies in patients at high risk for 
colonic cancer (patients with adenomas, longstanding ulcerative 
colitis, familial colon cancer syndromes) could give more insight in the 
relation between fiber consumption, bile acid metabolism and colonic 
cancer. Obvious is that we know too little about the mechanism 
whereby bile acids manipulate colonic carcinogenesis. More research 
is needed to clarify the interaction and possible beneficial effects of 
dietary fiber on the metabolism of secondary bile acids. 
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Abstract. 
Soluble secondary bile acids in the colon are supposed to be 
cytotoxic for normal colonic cells, resulting in an increased 
compensatory proliferation of colonic crypt cells, which is associated 
with an increased risk for colonic cancer. We developed a sensitive 
method to determine cytotoxicity of bile acids in the HT-29 colon 
cancer cell line, using a tetrazolium-based colorimetrie assay. Only in 
vital cells, tetrazolium-salts are converted into formazan, which can 
be measured easily. Chenodeoxycholic acid and deoxycholic acid 
(DCA) were cytotoxic in concentrations above 100 μΜ, which is in 
the physiological range for soluble DCA in feces. Conjugation of bile 
acids diminished cytotoxicity 7-10 fold. In this concentration range, 
no effect of calcium or calciumphosphate was demonstrated, 
suggesting that the effect of calcium on colonic proliferation is not 
mediated by a precipitation of soluble bile acids in the large bowel. 
Finally, we could demonstrate a significant correlation between the 
cytotoxicity of the aqueous phase of feces and the soluble DCA 
concentration. 
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Introduction. 
Secondary bile acids have been implicated in colonic carcinogen­
esis1'3. The exact mode of action has not yet been clarified, but is 
supposed to be mediated by a cytotoxic effect on the colonic 
mucosa. Most bile acids are cytotoxic to cells, probably by co-
micellisation with phospholipids in the cell membrane 4'5. Therefore it 
has been postulated that bile acids are only cytotoxic above the 
critical micellar concentration 5,e. Another mechanism could be the 
formation of soaps with calcium in the cell membrane, resulting in the 
formation of micro-channels 7 B . This cytotoxicity can cause epithelial 
cell loss in the large bowel leading to a compensatory crypt cell 
proliferation 9. It has been shown that an increased cell proliferation 
has been linked to a higher risk for the development of colonic cancer 
10,1
 \ One of the proposed mechanisms is an increased susceptibility 
of the colonic mucosa for mutagenic substances, because of the 
higher fraction of S-phase cells. 
Most bile acids in the lumen of the large bowel are bound to food 
residue and bacterial mass. This leaves only a minor fraction in the 
soluble form and thus in contact with colonic mucosal cells. In man 
more than 95% of the secondary bile acids consist of deoxycholic 
acid (DCA) and the -almost insoluble- lithocholic acid (LCA). The total 
concentration of bile acids in the aqueous phase of stool ranges from 
50 to 300 //M. DCA is the main soluble bile acid ranging from 10 to 
200 μΜ 12. 
Cytotoxicity has been measured by an erythrocyte lysis assay 5 · 1 2 1 4 in 
this assay erythrocytes are incubated with bile acid solutions and 
lysis of the erythrocytes is measured by counting intact cells before 
and after incubation 12 or by the release of iron from destroyed cells 5. 
In this assay cytotoxicity of secondary bile acids has been demon­
strated in micellar concentrations above 1 to 2 mM. These 
concentrations are much higher than have been found in the aqueous 
phase of stool. If cytotoxicity of bile acids is indeed the result of co-
micellisation with phospholipids in the cell membrane, for which a 
micellar concentration is needed, the concentration of the soluble bile 
acids in the large bowel is far to low to cause this cytotoxic effect. 
We therefore developed a sensitive and accurate method to determine 
the cytotoxicity of bile acids in low concentrations, as has been found 
in the fecal water, on cultured HT-29 colon cancer cells. With this 
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assay we could also measure the cytotoxicity of fecal water. 
Furthermore we used this cytotoxicity assay to study the effect of 
calcium and calciumphosphate (CaP,) on solutions with bile acids in 
low concentration. Controversy exists on the effects of calcium or 
Ca Pi on precipitation and cytotoxicity of bile acids and again, studies 
are done with bile acids in micellar concentrations. To gain insight in 
the interaction of bile acids and calcium in large bowel, we investiga­
ted the effect of calcium and CaP, on submicellar bile acid concentra­
tions, present in the aqueous phase of stool. 
Material and methods. 
HT-29 lysis assay. 
Cholic acid (CA), DCA, chenodeoxycholic acid (CDCA), ursodeoxy­
cholic acid (UDCA), and glyco- and tauro- conjugates were purchased 
from Sigma (St Louis, USA) and Calbiochem (San Diego, USA). As 
previously described 15, the colonic cancer cell-line HT-29 was cul­
tured in Dulbecco's Modified Eagle's Medium (DMEM, Flow Labora­
tories Irvine, Scotland) until 90% confluence. After trypsinization, 
cells were resuspended and plated in 96 multi-well plates (Costar, 
Cambridge, Mass, USA) with a concentration of 15.000 cells/well. 
After 48 hours culture (37°C, 5% C02) cells were washed and 
incubated during 1 hour with 100 μ\ bile acids solutions in phosphate 
buffered saline (PBS) or with 100 μ\ of the aqueous phase of stool. 
The concentrations of bile acids ranged from 0-3200 //mol/l. Every 
experiment with a single concentration was performed in octuple. In a 
number of experiments CaCI2 and/or sodiumphosphate was added to 
the incubation mixture to a final concentration of 10 mM. After 1 
hour incubation, cells were washed and cultured for another 48 hours 
with DMEM. Then 20 μ\ of the tetrazolium salt 3-(4,5,-dimethyl-
thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT, 1 mg/ml) was ad­
ded to every well. In the viable cells, MTT will be converted by 
mitochondrial activity to formazan, a blue dye 1β"18. After four hours 
cells were washed and lysis was carried out with 100 μ\ dimethylsulf-
oxide to free the formed formazan. Absorption was read at 545 nm 
using a Multiscan (Flow, Helsinki, Finland). The cell survival was 
expressed as percentage absorption of the maximal absorption, read 
from the wells incubated with PBS without bile acids. 
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Erythrocyte lysis assay. 
Blood was collected from healthy donors by venipuncture with 
syringes containing EDTA. Erythrocytes were washed three times 
with 5 vol of buffer (150 mM NaCI, 25 mM glucose, 10 mM Tris-HCI 
at Ph 7.4), as described by Rafter et all 12. Cells were incubated in 
triplo with bile acid solutions at a final haematocrit of 10% in a total 
volume of 500 μ\. After 6 hours incubation, erythrocytes were 
counted using a Coulter Counter ZM (Coulter Electronics, England). 
The cell survival was expressed as percentage cells, compared with a 
control incubation with PBS. 
Preparation of the aqueous fraction of stool. 
Stool samples were collected from healthy volunteers on dry ice and 
in the laboratory stored at -20 °C until processing. Samples were 
homogenized with a blender and ultracentrifugated (2 hr, 4°C, 
30.000g). The supernatant was carefully removed and filtered (0.2// 
filter, Schleicher & Schuell, Dassel, Germany). This fecal water 
fraction (FW) was stored at -20°С until analysis. 
Bile acid analysis. 
Bile acids were determined as published before 19, with slight modi­
fications. After enzymatic hydrolysis the bile acids were extracted 
from fecal water (0.5 ml) by SepPak C18 chromatography. The 
saponifiable conjugates were then hydrolyzed at 60°C for 2 h in 1 ml 
of 1 M КОН in methanol. The unconjugated bile acids were separated 
from the neutral sterols by Lipidex DEAP chromatography and 
measured after methylation and silylation by capillary gas chromatog­
raphy (column CP Sil 5CB) on a Packard 430 gas Chromatograph. 
Statistics. 
For every cytotoxicity-experiment, a survival curve was calculated 
according to the formula: P= 1/1 + exp[b[\n(concentration)-a)], in 
which Ρ is the fraction surviving cells, b is the slope of the curve and 
a is the concentration resulting in 50% cell-lysis (LC50). Using non 
linear regression, for every experiment those curves were fitted 
simultaneously assuming parameter b was the same. The LC50 
values were compared using Wald statistics. Bonferroni corrections 
were applied because of multiple testing. 
A Spearman Rank Correlation Coefficient (rs) was calculated to test 
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the relation between cytotoxicity and bile acid concentration in fecal 
water. 
Statistic calculations were carried out with the SAS analysis system. 
Results. 
Validation of the HT-29 assay. 
We measured the cytotoxicity of unconjugated DCA in both the HT-
29 assay and the erythrocyte lysis assay. Visual inspection with a 
microscope shortly after the incubation showed a complete lysis of 
the cells in the cytotoxic concentrations. As demonstrated in figure 1, 
the HT-29 assay is about 10 times more sensitive than the 
erythrocyte assay and the cytotoxic potential of DCA is quantifiable in 
concentrations above 100 //mol/l. This concentration correlates well 
with the range found in the aqueous phase of feces. 
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Figure 1. Cytotoxicity of unconjugated DCA in the erythrocyte lysis assay 
compared to the HT-29 cell assay. Cytotoxicity is expressed as the percentage of 
maximal cell survival (mean ± S.E.M.). 
LC50 of HT-29 vs erythrocyte assay: p< 0.00011 
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Figure 2. Cytotoxicity of the most important unconjugated (A) bile acids. In the 
mixture of DCA and CDCA, concentrations of individual bile acids are given. The 
LC50 of DCA vs DCA + CDCA and of CDCA vs DCA + CDCA: p<0.0001. 
Conjugation of DCA (В) and CDCA (C) results in a significant decrease in 
cytotoxicity. LC50 of glyco-DCA vs DCA, tauro-DCA vs DCA, glyco-CDCA vs 
CDCA and of tauro-CDCA vs CDCA: ρ < 0.0001. 
Cytotoxicity of bile acids. 
The cytotoxic potential of other bile acids has been displayed in figure 
2. For optical reasons only mean values are given, the standard error 
is like in figure 1 around 5 %. The cytotoxicity of both unconjugated 
dihydroxy bile acids DCA and CDCA is comparable and a 1:1 mixture 
of both bile acids resulted in a cumulated cytotoxicity. 
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Table 1. Cytotoxicity of conjugated and unconjugated bile acids. 
BILE ACID 
DCA 
Glyco-DCA 
Tauro-DCA 
CDCA 
Glyco-CDCA 
Tauro-CDCA 
CA 
UDCA 
LC50 (μΜ) 
192 
1111 
1745 
210 
1067 
2715 
>3200 
>3200 
95% Confidence 
177- 205 
1015- 1219 
1626- 1855 
191- 230 
9 7 5 - 1169 
2607 - 2833 
The LC50 (μΜ) is the concentration resulting in 50% of the maximal cell survival. 
CA and UDCA were not cytotoxic up to concentrations of 3200 μΜ. All 
conjugated bile acids vs unconjugated forms: p<0.0001; glyco vs tauro 
conjugated bile acids: ρ < 0.0001; DCA vs CDCA: n.s. 
The cytotoxicity decreased 7-10 fold for taurine or glycine conjugated 
DCA and CDCA (figure 2). In contrast, no cytotoxicity was found for 
CA and UDCA in concentrations up to 3200 //mol/l. The LC50 values 
of all tested bile acids are given in table 1. 
Effect of Calcium and Calciumphosphate (CaP, ). 
We studied the effect of calcium and CaP, on the cytotoxicity of DCA 
and CDCA in concentrations present in the aqueous phase of stool. 
The cytotoxicity of the bile acids increased after addition of CaCI2 in a 
final concentration of 10 mM (p<0.0001). 
No protective effect of 10 mM CaP, on bile acid cytotoxicity was 
demonstrated when equimolair quantities of CaCI2 and sodiumphosp-
hate (Ph = 7.40, final concentration 10 nM) were added to form CaP,. 
This resulted only in a partial inhibition of the increase in cytotoxicity 
which was seen after addition of CaCI2. For Sodiumphosphate itself 
no protective effect on bile acid cytotoxicity was seen (Figure 3). 
Cytotoxicity of fecal water. 
To study the cytotoxic effect of soluble bile acids in stool, fecal water 
was prepared from 22 stool samples from healthy volunteers. The 
cytotoxicity of those samples was determined with the HT-29 assay, 
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Figure 3. The effect of calcium, phosphate and CaP, on cytotoxicity of DCA. 
LC50 of DCA vs DCA + Ca: ρ<0.0001; DCA vs DCA + CaP; ρ<O.00O1; DCA vs 
DCA+P04:n.s. 
and bile acids were measured by gaschromatography. A significant 
correlation was found between the cytotoxicity and the concentration 
of the most important soluble bile acid DCA, as represented in figure 
4 ( r s = -0.44, ρ<0.05). It is important to mention that several FW 
samples with low DCA concentration showed a marked cytotoxicity. 
Other bile acids (CDCA, CA, LCA) were present in very low 
concentrations and did not show any correlation with cytotoxicity. 
Discussion. 
The determination of the cytotoxicity of the major bile acids as well 
as of the aqueous phase of feces using this HT-29 assay gives 
reproducible results. With this method it is possible to perform 
cytotoxicity experiments on large scale. Compared to the erythrocyte 
lysis assay, the HT-29 assay is more sensitive for the cytotoxicity of 
bile acids. Bile acids, in concentrations physiologically present in fecal 
water, are cytotoxic in this assay. 
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Figure 4. Relation between cytotoxicity and DCA concentration in the aqueous 
phase of feces. frs= -0.44, ρ<0.05). 
We can only speculate about the role of action of cytotoxicity of bile 
acids. If indeed the effect on the cell membrane is the most important 
effect 14,2° then the difference in cell membrane composition between 
erythrocytes and HT-29 cells could be the explanation for the 
observed difference in sensitivity between both assay's. The 
particular structure of the intestinal cell membrane 21 is quite different 
from erythrocytes. In contrast to erythrocytes, HT-29 cells are 
polarized cells 2223, with the apical side exposed to the bile acid 
solutions. This mimics the normal physiological situation in the large 
bowel. Furthermore it is conceivable that the unconjugated 
hydrophobic bile acids DCA and CDCA are rapidly transported into 
the cell. These bile acids could then exert a cytotoxic effect on the 
nucleus or in the cytoplasm. Especially mitochondria are sensitive to 
bile acids, and changes in mitochondrial morphology and function 
occur during the early phase of bile acid induced cytotoxicity 2 4 2 θ . 
This could be another explanation for the difference in sensitivity 
between the two assay's, since the metabolic activity in erythrocytes 
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is relative low. 
It seems possible that bile acids can induce mitochondrial dysfunction 
without immediate cell death 25. This may interfere with the presented 
cytotoxicity assay, as basicly mitochondrial function is measured. 
However, the absence of a gradual decline of tetrazolium conversion 
before cell lysis occurs, suggests that this is not the case. 
Furthermore, clear cell lysis was observed by microscopic inspection 
of the cultured cells after incubation with bile acids in concentrations 
that were cytotoxic in this assay. 
Only few data are available about the cytotoxicity of bile acids on 
other celltypes than erythrocytes. Two studies about the effect of 
DCA and CDCA on isolated rat hepatocytes demonstrated a cytotoxic 
effect at concentrations above 400 /лтюІ/І 2 7 , 2 β. In one study, the 
membrane-damaging effect of bile acids was measured on CaCo-2 
cells, a cancer cell line with small bowel-characteristics by quantifing 
the leakage of a fluorescent probe. Only micellar concentrations of 
bile acids were toxic e. 
The relative high cytotoxicity of the dihydroxy bile acids DCA and 
CDCA, compared to the more hydrophylic bile acids CA and UDCA, is 
in agreement with previous studies using other models 5 β 2 8 . The 
decrease of cytotoxicity, for both glycine and taurine conjugated DCA 
and CDCA has been demonstrated before in the erythrocyte model 5. 
Several hypotheses are suggested for the proposed protective effect 
of calcium on the colonic mucosa: a direct effect of Ca2+ on the 
mucosa 2 9, precipitation of bile acids with calcium in the small bowel 
or in the colon 3 0 or precipitation of bile acids with CaP, 5'31. Results 
about the in vitro precipitation of bile acids in micellar concentrations 
with calcium have been controversial. 5 · 3 1 3 5 . Calcium alone 3 2 3 4 or 
CaP, 5 Э 1 have been found to precipitate bile acids or to decrease 
cytotoxicity. In contrast, other studies showed a marked increase in 
cytotoxicity in the presence of calcium 5·8·35. it has been demon­
strated that the cytotoxicity of bile acids in sublytic concentrations is 
calcium dependent. Perhaps bile acids in low concentrations can 
promotion of the calcium uptake 8-35 which could be the factor leading 
to cellysis. Our data, showing a increased cytotoxicity after calcium 
addition, support this last theory. 
In studies by vd Meer 5,Э1 addition of CaP, but not CaCI2 to micellar 
bile acid solutions caused a decrease of soluble DCA from 2.0 mM to 
1.3 mM resulting in a disappearance of cytotoxicity in the erythrocyte 
Cytotoxicity of bile acids 65 
assay. In contrast to their data we found no protective effect of CaP,. 
This is probably caused by the difference in sensitivity between both 
assays, as the remaining DCA concentration after a possible precipita-
tion with CaP, is still about 1.3 mM which is cytotoxic in the HT-29 
assay but not in the less sensitive erythrocyte assay. 
It is unclear wether calcium or CaP, can precipitate bile acids in 
concentrations present in the soluble phase of stool. We hypothesize 
that if this is true, the remaining concentration of soluble bile acids 
will still be cytotoxic. Van der Meer demonstrated after calcium 
suppletion a change in biliary bile composition, but not in the soluble 
bile acids in the large bowel31. 
Finally for the first time a correlation was demonstrated between 
cytotoxicity and DCA concentration in fecal water. This supports the 
theory that DCA is a significant contributor to the cytotoxic potential 
of fecal water. The DCA-concentrations at which cytotoxicity was 
found are much lower compared to the in vitro experiments. The 
observation that even fecal water samples with a low DCA 
concentration showed a marked cytotoxicity, suggests that other 
factors play an important role in this interaction. For example, it has 
been demonstrated that fatty acids are cytotoxic to colonocytes 32,3e, 
and that the cytotoxicity of fecal water was consistently associated 
with those fractions that contained free bile and fatty acids 37. 
Furthermore, recently it has been shown that bile acids and fatty 
acids have a synergetic effect on cytotoxicity in the erythrocyte 
model 3e. This increase in cytotoxicity was most marked for the 
secondary bile acids deoxycholic and lithocholic acid. Unfortunately, 
it was not possible to measure fatty acids in fecal water in the 
present study. Further studies are necessary to elucidate other factors 
that are responsible for the cytotoxicity of colonic contents and to 
investigate its clinical relevance in carcinogenesis. 
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Abstract. 
Proliferating Cell Nuclear Antigen (PCNA) is a cell cycle related 
nuclear antigen, expressed in late G1-, S-, and early G2- phase. 
Recently, it has been used in assessing cellular proliferation. In 
contrast to the more traditional methods to determine cellular 
proliferation like [3H]-Thymidine or Bromodeoxyuridine, no incubation 
of fresh tissue is necessary when using PCNA ¡mmunohistochemistry. 
In this study, the concordance between PCNA immunostaining with a 
PC-10 antibody and [3H]-Thymidine autoradiography as an established 
S-phase marker, was investigated in human colonic mucosa using a 
double labelling technique. The intensity of PCNA immunostaining 
was classified as strong positive, weak positive or negative. Eighty-
three percent of the PCNA positive cells was strong PCNA-positive 
and 17% weak PCNA-positive. When only strong PCNA-positive cells 
were classified as PCNA positive, sensitivity and specificity of PCNA 
as a S-phase marker were 80 and 99.8% respectively. When both 
weak and strong PCNA-positive cells were classified as PCNA 
positive, sensitivity and specificity were 96 and 98%. 
We conclude that PC-10 immunostaining of human colonic mucosa 
after ethanol fixation is a useful S-phase marker in concordance with 
[3H]-Thymidine autoradiography. We suggest that besides strong 
PCNA-positive cells, also the less intense stained cells should be 
classified as PCNA positive. 
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Introduction. 
Assessment of colonic cell proliferation is of interest in clinical and 
experimental studies, because a sustained increased proliferation is 
supposed to play a role in the development of colonic neoplasia 1 3. 
Several methods have been used so far. In animals, proliferation can 
be measured after injection of [3H]-Thymidine by autoradiography of 
sections with incorporated [3H]-Thymidine or after injection of 
Bromodesoxyuridine (BrdU) by visualisation of the incorporated BrdU 
with a monoclonal antibody. In human studies only in vitro-incubation 
of tissue, after resection or biopsy, with [3H]-Thymidine or BrdU is 
possible. One of the disadvantages of these methods is, that incuba­
tion has to start immediately, with fresh tissue and under 
standardized conditions. This can be difficult, especially in larger 
scale multicenter studies. Another problem is the variability in tissue 
penetration of [3H]-Thymidine or BrdU, resulting in focal differences of 
the expression of the proliferation markers in the same tissue. 
Recently, cellular proliferation can be assessed using antibodies 
against Proliferating Cell Nuclear Antigen (PCNA) 4 Θ. PCNA is an 
evolutionary highly conserved 35 kD nuclear protein, also known as 
Cyclin or DNA Polymerase ¿-associated antigen 9. One of the major 
advantages of assessing proliferation with PCNA antibodies is, that 
no incorporation is necessary because PCNA is a natural occurring 
antigen. Originally, autoantibodies against PCNA were detected in 
serum of Systemic Lupus Erythematosus patients 10, later eleven 
different monoclonal antibodies were raised by Waseem and Lane " . 
One of the antibodies, PC-10, has been used in assessing cell prolifer-
ation of colonic mucosa. The expression of the antigen starts late in 
G1, is maximally in S-Phase and decreases in G2-phase 12. Compared 
to [3H]-Thymidine or BrdU, which are specific S-phase markers, PCNA 
is present during a longer period of the cell cycle. A methodological 
problem of the PCNA technique is the gradual increase and decrease 
of the antigen, resulting in a gradual scale of immunohistological 
staining. 
The present study was undertaken to correlate in a double labelling 
technique [3H]-Thymidine autoradiography with PCNA staining in 
human colonic tissue using a PC-10 monoclonal antibody. The first 
aim was to validate PC-10 immunostaining as a S-phase marker for 
human colonic mucosa. The second goal was to find out whether the 
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intensity of staining was related to the cell cycle. In other words: are 
only strong positive cells in S-phase or should strong and weak 
positive cells be counted to measure cellular proliferation? 
Material and Methods. 
Biopsies and sections: 
At least three colonic biopsies were taken by sigmoidoscopy from 10 
patients without colonic abnormalities. Biopsies were cut into small 
pieces of about 3 mm and stretched under a binocular microscope on 
a piece of filter paper with the mucosal surface side upside. Immedi­
ately afterwards, the material was incubated for 1 hour at 30 psi and 
37°C with DMEM medium (Flow laboratories, Irvine, Scotland) con­
taining 4 дСі/ml [3H]-Thymidine (Amersham International Pic, 
Buckinghamshire, UK) and fixed in 70% ethanol. The tissue was 
processed and 4 μπι sections were cut on poly-L-Lysine coated slides 
(Sigma, St Louis Mo USA). 
PCNA Immunostaining. 
After deparaffinization and blocking of endogenous peroxidase activ­
ity, sections were incubated with a PC-10 antibody (Dako, Glostrup, 
Denmark) for 1 hour in a 1:400 dilution in PBS at 24°C. After wash­
ing with PBS, a streptavidine-biotine system with AEC chromogen 
(Histostain-SP, Zymed Laboratories, San Francisco, CA, USA) was 
used to visualize the antibody. Counterstaining was performed with 
Mayer's haematoxyline during 10 seconds. 
Autoradiography of [3H]-Thymidine. 
After PCNA staining, slides were air dried and coated with NTB-2 
emulsion (Eastman Kodak, Rochester, USA). The exposure time was 
14 days. The autoradiographs were developed in Dektol (Kodak) and 
fixed. 
Scoring method. 
Sections were microscopically examined with a magnification of χ 
400. For PCNA, all homogeneous stained, distinct red cells (estimated 
as 75-100% of maximal staining intensity) were classified as strong 
PCNA-positive, less intens stained nuclei (estimated as 25-75% of 
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maximal staining intensity) were called weak PCNA-positive. For 
autoradiography all nuclei with at least 5 grains were assessed as 
[3Hl-Thymidine-positive. 
Results. 
The immunostaining for PCNA showed a low background staining and 
although most of the positive cells were strong positive, 17% showed 
a weak positive staining pattern. In the autoradiography, some parts 
of the sections showed none or very few grains, especially in the 
central parts of the tissue. Only those parts with a normal and homo-
geneous distribution of [3H]-Thymidine labelled cells were used for 
scoring. 
A total number of 10.000 cells were evaluated, approximately 1000 
for every patient. Every single cell was scored in PCNA staining as 
negative, weak positive or strong positive and in [3H)-Thymidine 
labelling as negative or positive. In most of the cells [3H]-Thymidine 
labelling and PCNA-staining were in accordance, although some of 
the cells showed only PCNA-staining or |3H]-Thymidine positivity 
(figure 1). In table 1, the distribution of cells is given when only 
strong PCNA-positive cells were classified as positive. 
Table 1: Distribution of [3H]-Thymidine and PCNA labelled 
nuclei in human colonic mucosa, considering only 
PCNA strong positive cells as PCNA positive. 
PCNA+ PCNA-
[3H]-Thymidine+ 1048 266 
[3H]-Thymidine - 14 8545 
In table 2, both strong and weak PCNA-positive cells are classified as 
PCNA positive. 
Assuming [3H)-Thymidine as the golden standard for S-phase 
determination in colonic mucosa, sensitivity, specificity and positive 
and negative predictive value of PCNA immunostaining compared to 
PCNA and 3H-Thymidine double-labelling 75 
Table 2: Distribution of [3H]-Thymidine and PCNA labelled 
nuclei in human colonic mucosa, considering PCNA weak 
and strong positive cells as PCNA positive. 
PCNA+ PCNA-
[3H]-Thymidine + 1265 49 
[3H]-Thymidine - 161 8398 
[3H]-Thymidine are given in table 3. When only strong PCNA-positive 
cells are assessed as positive, this method gives an sensitivity of 
80% and a specificity of more than 99% for determination of cells in 
S-phase. From the 364 weak PCNA-positive cells 217 cells (60%) are 
also [3H]-Thymidine positive, while 147 (40%) were [3H]-Thymidine 
negative. 
Table 3: Sensitivity, specificity and predictive values for PCNA as 
S-phase marker, compared to [3H]-Thymidine labelling. 
strong PCNA-positive 
cells 
sensitivity 0.80 
specificity 0.998 
positive predictive value 0.99 
negative predictive value 0.97 
all PCNA-positive 
cells 
0.96 
0.98 
0.88 
0.99 
In the left column data are given when only strong PCNA positive cells were 
assessed positive, in the right column data are given when strong and weak 
positive cells are classified as PCNA positive. 
When both weak and strong PCNA-positive cells are assessed as 
PCNA-positive, the sensitivity of PCNA staining as S-phase marker 
increased to 96%, specificity was 98%. The positive predictive value 
decreased slightly to 88%. 
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Figure 1 : Double labelled section of human colonic tissue, original magnification χ 
400. A: [3H]-Thymidine positive and strong PCNA-positive cell, B: [3H]-Thymidine 
positive and weak PCNA-positive cell, C: [3H]-Thymidine negative and PCNA-
positive cell, D: [3H]-Thymidine positive and PCNA-negative cell. 
Discussion. 
The measurement of colonic cell proliferation is currently used as an 
intermediated endpoint in intervention studies in patients at risk for 
developing colonic cancer 1 3 , 1 4. These studies are often multicentric. 
PCNA immunostaining has the major advantage of a simple handling 
of mucosal biopsies without incubation. Because PCNA 
immunostaining is a relatively new technique, only few data are 
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available about validation of PCNA as S-phase or proliferation marker, 
especially in human tissue. 
Data about the correlation between PCNA and BrdU or [3H]-Thymidine 
in cancer cell cultures are conflicting, depending on the type of cell 
line, the antibody used and the method of fixation 7 8 · 1 5 1 7 . The lack of 
a relationship between PCNA and cell cycle in some of the cell lines is 
probably caused by the high proliferation rate and the long half life of 
PCNA. Presumably, this is also the explanation of the observed 
discrepancy between PCNA immunostaining and flow cytometric data 
in several 7 ,1β, but not all tumours 4-19. 
In rat, in vivo incorporation of [3H]-Thymidine 5'17-20 or BrdU θ'17 
correlates well with PCNA labelling in different tissues, although in 
most studies after formaldehyde fixation, PCNA showed in general a 
2 times higher labelling index 5,8,2°. Galand et al performed a double 
labelling study of PCNA and [3H]-Thymidine in rats 5. They found that 
in methanol fixed intestinal tissue, 13% of PCNA positive cells were 
negative for [3H]-Thymidine and 14% of [3H]-Thymidine positive cells 
were negative for PCNA. In contrast, after formalin fixation, 4 1 % of 
PCNA positive cells were [3H]-Thymidine negative. 
This difference in PCNA immunostaining after alcohol or formaldehyde 
fixation has been confirmed by others 1β'21 and is important in 
interpretating results of different studies. This might be explained by 
the observation that two different populations of PCNA exist during 
the cell cycle " . One is a nucleoplasm^ form of PCNA, present during 
the whole cell cycle and easily extracted, depending on the method of 
fixation. The other form is strictly nuclear, and present during the S-
phase. If human colonic tissue is incubated with highly diluted PC-10 
antibody after ethanol fixation, this results, in our experience, in an 
intens nuclear staining of positive cells and a low nonspecific cyto-
plasmatic staining pattern. In contrast, after methanol fixation a high 
non-specific cyto-plasmatic staining was obtained (data not 
presented). In human tonsillar tissue, PC-10 immunostaining was 
optimal after alcohol fixation 21. 
At this moment, data about PCNA immunostaining of human colonic 
mucosa are scarce. After formalin fixation, a 50% labelling index has 
been found e, which is much higher than BrdU or [3H]-Thymidine 
labelling. Again this is probably related to the fixation procedure. We 
found in this study, using the combination of ethanol fixation and PC-
10 immunostaining, a labelling index of about 10% which correlates 
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well w i th the [3H]-Thymidine labelling. To our knowledge, this is the 
first study about the concordance between PCNA immunostaining 
and [3H]-Thymidine labelling in human colonic mucosa. 
In the present study we also investigated whether the intensity of 
PCNA-immunostaining is of importance in relation to the S-phase 
determination. 
The cells w i th a strong positive PCNA immunostaining pattern will be 
in S-phase, but when we consider only those cells as PCNA positive, 
a 20 percent underestimation of S-phase fraction as determined wi th 
[3H]-Thymidine labelling was found. On the other hand, 40 % of the 
weak PCNA-positive cells was [3H]-Thymidine negative. We assume 
that these cells have just passed the S-phase and PCNA is - in smaller 
quantities - still present because of its relative long half life. 
In human studies, cell kinetic parameters are frequently used as 
intermediate risk markers. In this context, the question arises if 
measuring only S-phase cells (in particular only strong PCNA-positive 
cells) wil l give more information than determination of the total PCNA 
positive cell fraction. Most of these cells are in S-phase (89%) and 
the remaining fraction is supposed to be in the late G1 or early G2. To 
our opinion, these cells should be taken into account in the 
determination of the labelling index, as they all belong to the prolifer-
ating fraction of cells. 
In summary, we demonstrated that PC-10 immunostaining after 
ethanol fixation is a good S-phase marker, in concordance wi th [3H]-
Thymidine autoradiography. We would stress the importance of 
agreement between different laboratories in fixation procedures and in 
classifying PCNA cells as positive or negative. We suggest to 
consider both strong and weak PCNA-positive cells as positive. 
Studies are in progress to assess the clini-cal relevance of PCNA as a 
proliferation marker in human colonic mucosa. 
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Abstract. 
Fecal inocula from 17 healthy volunteers were incubated under 
anaerobic conditions with the rapidly fermentable substrate lactulose 
and with the resistant starch compound native amylomaize. Seven 
mixtures produced high amounts of methane, 10 mixtures low 
amounts. In the mixtures with a high methane production, fermentati-
on of lactulose resulted in hydrogen production, which disappeared at 
the end of the incubation period. The methane production steadily 
increased. In these inocula, amylomaize fermentation resulted only in 
methane production. In the mixtures with a low methane production, 
only hydrogen was released both after lactulose and amylomaize 
fermentation. Although large interindividual differences existed, 
fermentation of both substrates seemed to elapse more rapidly in low 
compared with high methane producing inocula. Fermentation of 
lactulose and amylomaize starch resulted in an increase of the total 
short chain fatty acid concentration and in a relative enrichment of 
the butyrate fraction, from 10 to 17% (p<0.001). 
We conclude that fermentation of lactulose and of the resistant starch 
amylomaize yielded comparable amounts of short chain fatty acids, 
and that both substrates gave an enrichment of the butyrate-fraction. 
No significant differences could be demonstrated between low and 
high methane producing fecal inocula. 
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Introduction. 
Fermentation is the degradation of carbohydrates by anaerobic 
bacteria. Amongst the several substrates available, fibre, non-
digested starch and protein are quantitatively the most important \ 
Until recently, starch was believed to be completely digested in the 
small bowel. However, depending on the physical form and the way 
of food-processing, a substantial part of ingested starch will escape 
small bowel digestion and reach the colon 2"5 to provide substrate for 
the bacterial flora. Fermentation will result in the production of short 
chain fatty acids (SCFA) and the gasses hydrogen (H2), methane 
(CH4) and carbon-dioxide (C02). Methane is formed out of carbon-
dioxide and hydrogen in approximately half of the Western population 
by the bacterial species Methanobrevibacter Smithii ". Hydrogen can 
also be metabolised to acetate 7 or it can reduce sulphate into 
hydrogensulfide (H2S) 8. Hydrogen and methane are excreted by 
breath or by flatus 9. It has been suggested that subjects, excreting 
large amounts of methane are at an increased risk for colon cancer 
10,11
.The most important SCFA's are acetic acid, propionic acid and 
butyric acid, which are supposed to play an important role in large 
bowel homeostasis and metabolism 12. These acids are the most 
important energy source for colonocytes 13,14, and a deficiency of 
SCFA's may be the causative factor in the pathogenesis of ulcerative 
colitis 15. Furthermore, they might be protective in large bowel 
carcinogenesis. The SCFA related decrease in intraluminal pH is 
supposed to diminish the formation of carcinogens 16,17. Moreover, 
butyrate is of special interest because it has a differentiating and 
growth-regulating potential 18"21. Depending on the substrate for 
fermentation, differences in rate and proportional production of SCFA 
have been observed 22"24. A relatively high yield of butyrate has been 
demonstrated when starch is fermented. 
To gain insight into fermentation of resistant starch and into the 
possible differences between low and high methane producing fecal 
flora, fecal samples from methane and non-methane excreting 
subjects were incubated with lactulose and with the resistant starch 
compound amylomaize. Hydrogen and methane formation, pH, and 
short chain fatty acid production were measured as a gauge for 
fermentation. 
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Materials and Methods. 
Study protocol. Fresh fecal samples were obtained from 17 healthy 
volunteers. Within 10 min, 50 g of stool was diluted with Sodium 
Phosphate buffer (0,1M, pH = 6.5) to a final concentration of 16 % 
(w/v) and blended under oxygen free nitrogen to maintain anaerobio-
sis. The substrates used were lactulose (Inpharzam, Almere, The 
Netherlands) and native amylomaize starch (Hylon VII, National Starch 
& Chemical Company, Zutphen, The Netherlands). Five ml of this 
fecal slurry was mixed in 20 ml vials with 50 mg lactulose, 50 mg 
native amylomaize, or without extra substrate, flushed with oxygen 
free nitrogen and sealed. The total of 30 vials was incubated in a 
shaking waterbath at 37 °C. Two lactulose vials, two amylomaize 
vials, and two control vials were removed at the start and after 2 hr, 
4 hr, 8 hr and 24 hr. Samples were taken from the gas-phase for 
measurement of hydrogen and methane, pH was measured and the 
slurry was centrifugated with 10.000g, during 5 min at 4°C. The 
supernatant was removed, snap frozen in liquid nitrogen, and stored 
at -20°C until analysis. 
Hydrogen measurement. 
A 0.5 ml sample of the head space was injected in triplo into a 
Packard gas-chromatograph with a Porapak Q 80-100 mesh column 
and a temperature of 110°C. Calibration was done with a 50.000 
ppm and a 100.000 ppm standard gas. 
Methane measurement. 
A 0.4 ml gas sample was injected in triplo into a Pye gas-chromato­
graph, with a Porapak Q 100-120 mesh column and a column 
temperature of 50°C. Calibration was done with a 30 ppm standard 
gas. In methane concentrations above 60 ppm, samples were diluted 
and injected again. 
Short chain fatty acid analysis. 
Ten μ\ of a solution of 0.17 M 2-ethylbutyric acid (internal standard) 
in 100% formic acid was added to 100 μ\ of the supernatant. The 
mixture was centrifugated and 0.7 μ\ of the resulting clear super­
natant was directly injected in a Packard gas Chromatograph (column: 
10% SP1200 / 1 % H3P04 on 80/100 Chromosorb WAW). The 
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injection port of the Chromatograph was installed wi th an 8 cm long 
glass liner w i t h an internal diameter of 3 mm, stoppered wi th a glass 
wool plug. Injection was performed in the space inside the liner above 
the glass wool plug. Details of the gas-chromatographic separation of 
SCFA's have been described elsewhere 2 5. 
Statistical analysis. 
All values are given as mean ± sem, unless specified. 
Short chain fatty acid production, pH and gas formation were used as 
gauge for fermentation. Differences in these parameters between 
lactulose-, amylomaize-, or control fermentation were tested wi th the 
Friedman test. Differences between low- and high-methane producing 
inocula were tested with a Wilcoxon rank test, the difference in 
fermentation rate was estimated according to Koziol 2Θ 
Table 1. Production of hydrogen and methane (mean ± sem) of 7 
high-methane and 10 low-methane producing human fecal inocula 
after 24 hour with or without supplementation with 50 mg native 
amylomaize or lactulose. 
hydrogen methane H2-equivalent 
μΙ μΙ μ\ 
high methane producing inocula 
control 2.3 ±1.2 298 ± 8 1 " 1148±212 b 
amylomaize 0 . 2 ± 0 . 1 ь 7 9 3 ± 1 6 7 " b 3 5 5 9 ± 5 9 8 ' b 
lactulose 4 0 ± 3 4 a b 6 7 9 ± 1 6 8 a b 3 0 6 8 ± 6 2 9 a b 
low-methane producing inocula 
control 7.1 ±1.8 5.8±3.1 3 2 ± 1 3 
amylomaize 1 4 8 ± 5 1 a 5.8±3.1 173 ± 58' 
lactulose 464±135" 0.6±0.2 4 6 7 ± 1 3 5 a 
Not all hydrogen measurements were availible from one high methane producing 
inoculum. Hydrogen production and Η ¡-equivalents were calculated from the 
remaining 6 HMP inocula. 
' p<0.05 compared with control incubations, b p<0.01, compared with low-
methane producing inocula. 
In-vitro fermentation of resistant starch 87 
Results. 
Gas-production. 
The methane production of incubation mixtures showed a bimodai 
distribution. In 10 mixtures less than 3 μ\ methane was produced 
(range 0.1-2 μ\) after 24 hour fermentation of lactulose, in the other 7 
samples at least 100 //1 was produced (range 100-1060 //I). Methane 
production after amylomaize starch supplementation showed a 
comparable distribution, with low production in the same fecal 
samples. An arbitrary limit of 100 /yl/24hr methane in the lactulose 
incubations was taken to classify fecal inocula as high-methane 
producing mixtures (HMP) or low-methane producing mixtures (LMP). 
The gas production after 24 hr incubation for HMP and LMP mixtures 
is given in table 1. 
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Figure 1: Mean hydrogen and methane production during fermentation of 50 mg 
lactulose (A) or native amylomaize IB) by seven high-methane producing fecal 
inocula. Bars indicate one standard error of the mean. 
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The CH4-production significantly increased in HMP mixtures during 
lactulose and amylomaize fermentation, compared to control incubati­
ons (p<0.05). The hydrogen production in the control-incubations 
was minimal, in HMP 2.3 ± 1.2 μ\ and in LMP 7.1 ± 1.8 μ\ after 24 
hours. The HMP mixtures produced only a small amount of hydrogen 
after 24 hr incubation with either substrate, in contrast to LMP 
mixtures, in which a considerable amount of hydrogen was produced 
(table 1). 
The mean hydrogen and methane production of the HMP inocula 
during fermentation of lactulose and amylomaize is given in figure 1. 
Amylomaize fermentation resulted in a steadily increasing methane 
production. During the first 4 hours of lactulose fermentation, both 
hydrogen and methane were released, but hydrogen disappeared 
thereafter from the headspace. In LMP mixtures, the hydrogen 
production also increased faster during lactulose compared with 
amylomaize fermentation. 
Table 2. Decrease in pH (mean ± sem) of 7 high-methane and 10 
low-methane producing fecal inocula after 24 hr with or without 
supplementation with 50 mg native amylomaize or lactulose. 
substrate 
control 
amylomaize 
lactulose 
high-methane inocula 
0.30 ± 0.06 
1.33 ± 0.13" 
1.75 ± 0.06" 
low-methane inocula 
0.40 ± 0.08 
1.28 ± 0.16' 
1.83 ± 0.04' 
' p<0.05, compared with decrease of pH in control incubation. 
The difference between high- and low-methane producing inocula was not signifi­
cant. 
Acidity of the mixture. 
At the start of the incubations, the mean pH was 6.59 and this pH 
decreased significantly in the mixtures with amylomaize and lactulose 
(p<0.05), but not in the control incubations (table 2). The pH 
decreased faster and more marked in the lactulose incubation 
compared to the amylomaize incubation (p<0.01). No differences 
were observed between HMP and LMP mixtures. 
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Short chain fatty acid production. 
The SCFA production rose gradually during the 24 hr incubation and 
reached twice the amount of SCFA in the mixtures w i t h lactulose and 
starch compared to the control incubations (table 3). Lactulose was 
more rapidly fermented than amylomaize, and the former process was 
already completed at 8 hr. 
Table 3. Total short chain fatty acid concentration (mean ± sem) in 
mmol/l after 4, 8 and 24 hr incubation of 7 high-methane and 10 low-
methane producing fecal inocula without supplementation or with 50 
mg native amylomaize or lactulose. 
substrate 4 hr 8 hr 24 hr 
high-methane producing inocula 
control 18.4±3.4 19.9±2.1 3 0 . 7 ± 5 . 3 
amylomaize 23.9±3.9 35.1 ± 4 . 8 ' 6 5 . 3 ± 8 . 7 ' 
lactulose 56.7±10.5" 76.9±8.5" 8 8 . 6 ± 7 . 9 ' 
low-methane producing inocula 
control 23.0±2.7 24.9±3.2 4 1 . 5 ± 6 . 9 
amylomaize 32.8±5.0 51.0±10.9' 72.4± 10.0' 
lactulose 75.6±7.6 ' 9 0 . 8 ± 6 . 8 ' 87.5 ±4.8" 
' P<0.02, compared with control incubations. 
Differences between high- and low- methane producing inocula were not signifi­
cant. 
The total 2 4 hr SCFA-production was not significantly different 
between lactulose and amylomaize mixtures. During the first eight 
hours of incubation, SCFA production tended to be higher in the LMP 
compared w i t h the HMP mixtures, but the difference was not 
statistically significant. 
The proportional distribution of the individual SCFA's changed during 
fermentation. The fraction butyrate increased from 1 0 % to 1 7 % after 
2 4 hr fermentation in the mixtures with lactulose or starch 
( p < 0 . 0 0 1 ) , but not in the control mixtures (table 4). No significant 
differences were found between LMP and HMP mixtures. 
At the start of the incubations, the molar ratio of acetate, propionate, 
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and butyrate was 65:17:10. After 24 hr fermentation of lactulose, the 
fraction of butyrate increased (p<0.001) and the ratio was 67:10:17. 
Comparable changes after 24 hours were seen in the amylomaize 
mixtures (ratio 62:12:17). 
Table 4. Concentration and molar fraction of butyrate (mean ± sem) 
in fecal inocula during fermentation with or without supplementation 
with 50 mg native amylomaize or lactulose. 
time 
fraction 
0 hr 
2h r 
4 h r 
8 hr 
24 hr 
control 
Butyrate 
mmol/l 
1.0±0.1 
1.7±0.2 
2.2±0.3 
2.4±0.3 
4 .7±1 .0 
fraction 
% 
10.1 
9.9 
10.4 
10.0 
11.7 
amylomaize 
Butyrate 
mmol/l 
1.1 ±0.1 
2.4±0.4 
3.5±0.6 
6.3±1.3 
11.8±1.2 
fraction 
% 
10.2 
10.9 
11.2 
13.2 
17.1 
lactulose 
Butyrate 
mmol/l 
1.1±0.2 
7.0±0.7 
10.0±1.0 
13.2±0.9 
15.0±0.9 
% 
9.2 
13.1 
14.8 
15.8 
17.3 
Discussion. 
This study demonstrates that the in vitro fermentation of lactulose 
and amylomaize results in an increased production of hydrogen, 
methane, and short chain fatty acids. Furthermore, the fraction of 
butyrate increased. The total SCFA production is comparable between 
HMP and LMP incubations, suggesting that the overall fermentation is 
comparable. The much lower hydrogen production in the LMP 
mixtures, compared to the calculated H2-equivalent in HMP mixtures 
is suggestive for a different pathway for hydrogen disposal in the low 
methane producing flora. Indeed, it has been demonstrated that 
hydrogen could be used by sulphate reducing bacteria to form H2S 8, 
and by acetogenic bacteria to produce acetate 7. Unfortunately, it 
was not possible to measure sulfide-compounds in this study. 
Lactulose is rapidly fermented, as can be seen from the increase in 
SCFA concentration. In HMP inocula, this resulted in the production 
and release of both hydrogen and methane during the first hours of 
incubation. After 2 hours, the hydrogen concentration decreased to 
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almost zero. We suppose that the formation of methane out of 
hydrogen is the rate limiting step in methanogenesis, and that the 
excess hydrogen is temporarily released into the headspace and 
utilized afterwards. In contrast, during the more slowly fermentation 
of amylomaize, HMP inocula released only methane. To our opinion, 
all hydrogen produced in these inocula was directly converted into 
methane. 
Both lactulose and amylomaize addition resulted in an increased SCFA 
production and in a decrease of the pH in the fecal samples. The 
production of SCFA's elapsed faster for lactulose compared to 
amylomaize. We speculate this is due to the more complex molecular 
structure of amylomaize compared to the disaccharide lactulose. It is 
obvious that the resistant starch must be broken into smaller 
fragments before final fermentation occurs. 
Differences in individual SCFA profiles have been previously 
described, depending on the substrate supplied. Emphasis has been 
put on the concentration and the proportional fraction of butyrate, 
because of its putative anti-neoplastic effects. However, data are 
conflicting. In some studies, fermentation of lactulose resulted in a 
decrease in the butyrate fraction 2 2 , 2 e, whilst other authors have found 
an unchanged fraction 2 9. Starch fermentation has been shown to 
increase the butyrate fraction 2 4 Э 0. In the present study we found an 
increased butyrate fraction both after lactulose and starch fermen­
tation, suggesting that the kind of substrate is not of major 
importance. 
The higher levels of SCFA's in the LMP mixtures during the first 8 
hours of incubation suggests a more rapid fermentation in these 
inocula. This finding is supported by a recent study which showed the 
same difference 2 4. However, the differences between LMP and HMP 
mixtures were not statistically significant in the present study. We 
assume that this is due to the large interindividual variation in the 
samples tested. 
In conclusion, this study shows that a resistant starch compound 
(amylomaize) produced equivalent amounts of hydrogen, methane and 
short chain fatty acids compared to lactulose in a fecal incubation 
system. However, the fermentation elapsed more slowly. The 
proportion of butyrate increased similarly for both substrates. No 
significant differences were found between low- and high- methane 
producing inocula. 
92 Chapter 6 
References: 
1. van Munster IP, Nagengast FM. The role of fermentation in colon cancer 
prevention. Scand J Gastroenterol 1994; 29:(in press). 
2. Anderson IH, Levine AS, Levitt MD. Incomplete absorption of the 
carbohydrate in all purpose wheat flour. New Engl J Med 1981; 
304:891-892. 
3. Stephen AM, Haddad AC, Philips SF. Passage of carbohydrate into the colon. 
Gastroenterology 1963; 85:589-595. 
4. Cummings JH, Englyst HN. Fermentation in the human large intestine and 
the available substrates. Am J Clin Nutr 1987;45:1243-1255. 
5. Englyst HN, Cummings JH. Digestion of polysaccharides of potato in the 
small intestine of man. Am J Clin Nutr 1987; 45:423-431. 
6. Miller TL, Wolin MJ. Methanogens in human and animal intestinal tracts. 
Syst Appi Microbiol 1986; 7:223-229. 
7. Lajoie SF, Bank S, Miller TL, Wolin MJ. Acetate production from hydrogen 
and 13C0carbon dioxide by the microflora of human feces. Appi Environ 
Microbiol 1988;54:2723-2727. 
8. Gibson GR, Cummings JH, Macfarlane GT, et al. Alternative pathways for 
hydrogen disposal during fermentation in the human colon. Gut 1990; 
31:679-683. 
9. Christ) SU, Murgatroyd PR, Gibson GR, Cummings JH. Production, 
metabolism, and excretion of hydrogen in the large intestine. 
Gastroenterology 1992; 102:1269-1277. 
10. Haines A, Dilawari J, Wiggins H, Metz G, Blendis L. Breath methane in 
patients with cancer of the large bowel. The Lancet 1977; 481-3. 
1 1 . Pique JM, Pallares M, Cuso E, Villar-Bonet J, Gassull MA. Methane 
production and colon cancer. Gastroenterology 1984; 87:601-605. 
12. Cummings JH. Fermentation in the human large intestine: Evidence and 
implications for health. The Lancet 1983; may 28:1206-1209. 
13. Roediger WEW. The role of anaerobe bacteria in the metabolic welfare of the 
colonic mucosa in man. Gut 1980; 21:793-798. 
14. Rowe WA, Bayless TM. Colonic short chain fatty acids: fuel from the lumen? 
Gastroenterology 1992; 103:336-339. 
15. Scheppach W, Sommer H, Kirchner Τ, et al. Effect of butyrate enemas on the 
colonic mucosa in distal ulcerative colitis. Gastroenterology 1992; 
103:51-56. 
16. Thornton JR. High colonic pH promotes colorectal cancer. The Lancet 1981; 
i: 1081-1083. 
17. Samelson SL, Nelson RL, Nyhus LM. Protective role of fecal pH in 
experimental colon carcinogenesis. J R Soc Med 1986; 78:230-233. 
18. Dexter DL, Lev R, McKendall GR, Mitchell P, Calabres P. Sodium 
butyrate-induced alteration of growth properties and glycogen levels in 
cultured human colon carcinoma cells. Histochem J 1984; 16:137-149. 
19. Gum JR, Kam WK, Byrd JC, Hicks JW, Sleisenger MH, Kim YS. Effects of 
In-vitro fermentation of resistant starch 93 
sodium butyrate on human colonic adenocarcinoma cells. Induction of 
placental-like alkaline phosphatase. J Biol Chem 1987; 262:1092-1097. 
20. Friedman E, Lightdale C, Winawer S. Effects of psyllium fiber and short-chain 
organic acids derived from fiber breakdown on colonic epithelial cells from 
high-risk patients. Cancer Lett 1988;43:121-124. 
2 1 . Whitehead RH, Young GP, Bhatal PS. Effects of short chain fatty acids on a 
new human colon carcinoma cell line (LM1215). Gut 1986; 27:1457-1463. 
22. Mortensen PB, Holtug K, Rasmussen HS. Short chain fatty acids production 
from mono- and disaccharides in a fecal incubation system: Implications for 
colonic fermentation of dietary fiber in humans. J Nutr 1988; 118:321-325. 
23. Eastwood MA, Brydon WG, Anderson DM. The effect of the polysaccharide 
composition and structure of dietary fibers on cecal fermentation and fecal 
excretion. Am J Clin Nutr 1986;44:51-55. 
24. Weaver GA, Krause JA, Miller TL, Wolin MJ. Cornstarch fermentation by the 
colonic microbial community yields more butyrate than does cabbage fiber 
fermentation; cornstarch fermentation rates correlate negatively with 
methanogenesis. Am J Clin Nutr 1992; 55:70-77. 
25. Tangerman A, van Schaik A, Meuwese-Arends MT, Van Tongeren JHM. 
Quantitative determination of C2-C8 volatile fatty acids in human serum by 
vacuum distillation and gas chromatography. Clin Chim Acta 1983; 
133:341-348. 
26. Koziol JA, Maxwell DA. A distribution-free test for tumor-growth curve 
analyses with application to an animal tumor immunotherapy experiment. 
Biometrics 1981; 37:383-390. 
27. Wolin MJ. Metabolic interactions among intestinal microorganisms. Am J 
Clin Nutr 1974; 27:1320-1328. 
28. Rasmussen HS, Holtug К, Andersen JR, Krag E, Mortensen PB. The influence 
of isphaghula husk and lactulose on the in vivo and in vitro production 
capacity of short chain fatty acids in humans. Scand J Gastroenterol 1987; 
22:406-410. 
29. Vince AJ, McNeil NI, Wager JD, Wrong OM. The effect of lactulose, pectin, 
arabinogalactan and cellulose on the production of organic acids and 
metabolism of ammonia by intestinal bacteria in a fecal incubation system. Br 
J Nutr 1990;63:17-26. 
30. Englyst HN, Hay S, Macfarlane GT. Polysaccharide break-down by mixed 
populations of human fecal bacteria. FEMS Microbiol Ecol 1987; 
95:163-171. 

Chapter 7 
The effect of resistant starch on breath 
hydrogen and methane excretion 
in healthy volunteers 
Ivo P. van Munster, Hilde M. de Boer, Margje С. Jansen, 
Anton F. de Haan, Martijn B. Katan, Johan M. van Amelsvoort 
and Fokko M. Nagengast. 
Am J Clin Nutr 1994; 59: 626-630 
96 Chapter 7 
In-vivo fermentation of resistant starch 97 
Abstract. 
Colonic fermentation of dietary carbohydrates and fiber might produce 
a protective effect against the development of large bowel cancer. 
Resistant starch, i.e. starch that escapes small bowel digestion, is a 
candidate fermentable substrate that has hitherto been little studied. 
We supplemented 19 healthy volunteers with 3x15 gram per day of 
native amylomaize (Hylon-VII), containing 28 gram of type II resistant 
starch, or with dextrins as a placebo for seven days in a cross-over 
design. Pre-experimentally, 11 subjects regularly produced breath 
methane an 8 did not. Resistant starch increased 24-hour integrated 
excretion of breath hydrogen. The mean rise relative to placebo was 
35% (P = 0.03) for all subjects, and 60% for 8 subjects not producing 
methane (P = 0.02). The 11 methane producers showed a 93% 
increase in breath methane excretion on resistant starch (P = 0.03). 
Continued consumption of 25 gram per day of type II resistant starch 
is well tolerated, and increases colonic fermentation in healthy 
volunteers. 
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Introduction. 
Starchy foods such as wheat, potatoes, and cassava are the main 
source of energy in most human diets. Cooking serves to release 
starch from the granules in which it is stored, and makes it available 
for digestion. Dietary starch is largely hydrolyzed and absorbed in the 
small bowel, but a part is resistant to digestion, depending on 
processing and type of starch 1"3. This resistant starch fraction enters 
the cecum and is a potential substrate for fermentation M . Fiber is 
another important source of fermentable carbohydrate, but high-fiber 
diets have proved less than attractive to most western people, and 
adherence to such diets is poor. Resistant starch might conceivably 
provide a useful alternative to fiber. However, very little is known 
about the actual fate of resistant starch in the colon. 
Dietary fiber can offer protection against the development of colonic 
cancer 5 8. Fermentation of fiber into short chain fatty acids is one of 
the proposed mechanisms for this effect. Thornton et al demonstrated 
that in patients with colonic neoplasms the fraction of dietary starch 
reaching the colon was smaller than in healthy controls 9. 
Resistant starch has been classified into 3 groups: type I represents 
physically inaccessible starch such as in intact or partly milled grains; 
type II consists of starch enclosed in granules, such as in raw potato 
or unripe bananas; and type III represents retrograded amylose1. 
The proportion of resistant starch in several foods has been calcu-
lated by feeding them to colectomized patients and determining the 
residual starch in the ileostomy output. The proportion of starch that 
was resistant to small bowel digestion and absorption varied from 1 % 
in potatoes 10 to 89% in unripe bananas 11. Molis et al intubated the 
cecum of healthy volunteers and found that 49% of ingested 
retrograded high amylose maize starch was recovered from the 
cecum 12. In common foods, only a relatively small proportion of 
dietary starch appears to be resistant starch 1-13. Using the intubation 
technique, Flourie et al 14 have demonstrated that 4% of starch in a 
average meal reaches the colon. Stephen et al used the same 
intubation technique and recovered 10% of starch in meals from the 
terminal ileum; In some subjects the figure was as high as 20% 1S. In 
general, such studies show 4-10% of dietary starch to be resistant to 
digestion. 
One endproduct of cecal fermentation of starch is hydrogen, which 
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can be measured in the expired brecth. If the colonic bacterial flora 
contains a sufficient amount of methanogenic bacteria, hydrogen will 
in its turn be used to synthesize methane Ίβ. This can be found in the 
expired air and flatus of approximately fifty percent of the western 
population 17. Therefore, the excretion of these two gasses can be 
used as a gauge for colonic fermentation 18. 
If indeed fermentation is the mechanism through which fiber has a 
protective effect on colon cancer development, we speculate that 
resistant starch could have the same effect. As far as we know, only 
a few single dose experiments have been done with resistant starch 
in human subjects, but no data are available of the effect of continu­
ed supplementation with resistant starch. Here we report the effects 
of one week feeding of 45 gram native amylomaize, containing 28 
gram resistant starch per day on colonic fermentation in healthy 
volunteers. 
Subjects and Methods. 
Hypothesis. 
The study was set up to test the following hypotheses: 
1. Resistant starch supplementation will cause a higher breath 
hydrogen excretion in both methane producers and non-methane 
producers than maltodextrin supplementation. 
2. Resistant starch supplementation will increase breath methane 
excretion in methane producers. 
Subjects and design. 
Twenty-two healthy male volunteers (mean age 46 yr, range 21-76) 
entered the study. Women were excluded because of the influence of 
the menstrual cycle on starch absorption and fermentation 19. Other 
exclusion criteria were: smoking, recent use of laxatives or antibiotics 
and previous or current bowel disease. Four breath samples were 
collected on two separated days from each volunteer before the 
study, so as to classify him as a methane excréter or non-excreter. A 
subject was classified as methane excréter when the methane 
concentration exceeded 3 ppm in 2 or more of the 4 breath-
samples20. Ten volunteers were non-excreters, and 12 were methane 
excreters. One non-methane excréter dropped out because of 
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influenza, and one excréter and one non-excreter provided insufficient 
breath samples, leaving a total of 19 who completed the trial 
successfully. 
The design was a two period, placebo-controlled cross-over study 
with periods of 7 days and a 7-day wash-out period between treat-
ments. During the last 3 days of each supplementation period, volun-
teers recor-ded their diet and any symptoms of abdominal discomfort 
in a special diary. The purpose and design of the study and the 
possible consequences of resistant starch consumption were tho-
roughly explained to the sub-jects, who then gave their informed 
consent in writing. The study was approved by the Human Experi-
mentation Committee of the Academic Hospital Nijmegen. 
Diets and food intake. 
Participants consumed their regular diets during the study, but they 
were asked to refrain from consuming beans and peas. During the 
supplementation periods, subjects consumed 3x15 gram per day of 
native amylomaize starch (Hylon-VII, National Starch & Chemical 
Company, Zutphen, The Netherlands) or 3x15 gram maltodextrin 
(Cerestar SF 01904, Cerestar Benelux BV, Sas van Gent, the 
Netherlands) with their meals. Native Hylon-VII contains a high 
proportion of amylose; about 62% on gross weight basis is type II 
resistant starch as determined by the in vitro method of Englyst et al 
21
. Consequently, 45 gram native amylomaize contains 28 gr resistant 
starch. Maltodextrin is a rapidly absorbable, partially hydrolyzed 
maize-starch. 
Diet composition was calculated from the dietary records using the 
1987 release of the Netherlands nutrient data bank. 
Bretth hydrogen and methane. 
The subjects collected breath samples in 60 mL syringes at 2 hr 
intervals from 8.00 am until 24.00 hr and again at 8.00 pm the next 
morning during the last 24 hours of each supplementation period. 
Immediately after breath collection another syringe was filled with 
ambient air, and both syringes were sealed. 
Hydrogen was measured within 24 hours after collection using a 
standard electrochemical cell. Calibration was performed with a 
standard gas (AGA-gas, Amsterdam, The Netherlands) with a 
hydrogen concentration of 95.7 ± 2.5 ppm. For the determination of 
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methane concentration, 0.4 mL breath samples were injected in 
triplicate into a Packard gas-chromatograph, equipped with a Porapak 
Q 100-120 mesh column at an oven temperature of 50°C. Calibration 
was done with a standard gas (AGA-gas, Amsterdam, The 
Netherlands, methane concentration 28.4 ± 0.4 ppm). The methane 
concentration in each breath sample was corrected for the concentra­
tion of the matching ambient air sample. 
Symptom score. 
On the final 3 days of each supplementation period, the volunteers 
scored complaints of bloating, flatulence, abdominal cramps, belching 
and diarrhea in a diary on a scale running from 0 (none) to 4 (severe). 
The mean value of the median symptom score was calculated for 
each complaint during both periods. 
Data analysis and statistics. 
All values are given as mean ± sem. The effect of resistant starch 
supplementation and maltodextrin supplementation on hydrogen and 
methane excretion , calculated as the area under the 24 hour time-
concentration curve, was tested one-tailed using the method of 
Pocock 22. With a confidence-level of σ = 0.10, no interaction could be 
demonstrated between period and supplementation. Under the 
assumption of equal period effects, differences between methane and 
non-methane producing subjects were tested with a two-way ANOVA 
without interaction (classifications: type of supplement, methane 
producer/non-producer). Calculations were done with the SAS 
analysis system. 
Results. 
As shown in table 1, values for carbohydrate and energy intake were 
those typically found in adult Dutch men. No significant differences in 
food intake were seen between treatments for either methane or non-
methane excreters. The 45 g/d of native amylomaize was well 
tolerated (table 2); only flatulence was somewhat increased. 
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Table 1. Intake of energy and carbohydrates from regular foods in 
volunteers participating in a controlled crossover trial on the 
fermentation of resistant starch. In addition, subjects received 45 g/d 
of native amylomaize (Hylon-VII) or of rapidly digestible starch 
(ma/todextrin) for 7 days each. 
Subjects N amylomaize maltodextrin 
Energy 
(MJ/24 hr) 
Mono and 
disaccharides 
(g/24hr) 
Starch 
(g/24hr) 
Dietary fiber 
(g/24hr) 
All 
Methane excreters 
Non-methane excreters 
All 
Methane excreters 
Non-methane excreters 
All 
Methane excreters 
Non-methane excreters 
All 
Methane excreters 
Non-methane excreters 
21 
12 
9 
21 
12 
9 
21 
12 
9 
21 
12 
9 
11.4 ± 2.4 
11.3 ± 2.4 
11.6 ± 2.5 
153 ± 43 
153 ± 51 
153 ± 32 
165 ± 41 
168 ± 43 
162 ± 40 
29 ± 11 
32 ± 13 
26 ± 7 
12.0 ± 2.7 
12.5 ± 3.2 
11.2 ± 1.7 
156 ± 30 
156 ± 33 
156 ± 29 
166 ± 59 
182 ± 65 
146 ± 45 
31 ± 14 
34 ± 18 
26 ± 7 
Table 2. Mean and range of symptom-scores as recorded by 21 subjects 
during supplementation with 45 g/d of native amylomaize (Hylon-VII) and of 
maltodextrin. Subjects scored symptoms on a scale from 0 (none) to 4 
(severe). 
Symptom amylomaize 
Mean range 
maltodextrin 
Mean 
0.3 
0.7 
0.2 
0.2 
0.0 
Range 
0-3 
0-2 
0-3 
0-1 
0-1 
Bloating 
Flatulence 
Cramps 
Belching 
Diarrhoea 
0.4 
1.4 
0.1 
0.2 
0.0 
0-2 
0-3 
0-1 
0-1 
0-1 
Values are means ± SD for days 5-7 of the combined supplementation periods 
and include those for two subjects who provided insufficient breath samples for H2 
and CH4 analysis. Differences between periods were not significant either 
biologically or statistically for any nutrient. 
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Hydrogen excretion. 
The hydrogen concentration in expired air ranged from 1.2 to 91.5 
ppm during consumption of resistant starch and from 0 to 57.6 ppm 
during the maltodextrin period. The mean hydrogen excretion rose 
during the day, and peaked late at night, several hours after the last 
dose of resistant starch (figure 1). 
A significant rise in integrated 24-hour hydrogen excretion during 
amylomaize supplementation relative to control treatment was found 
in both the whole group and in the subjects not excreting methane 
(table 3). The effect was more modest in methane excreters. 
Table 3. Mean 24-hour integrated breath hydrogen excretion (ppm χ 
hr) ± SEM of healthy subjects after seven days supplementation with 
45 g/d of native amylomaize (Hylon-VII) or maltodextrin. 
All subjects 
Methane excreters 
Non-methane excreters 
N 
19 + + 
11 
β 
amylomaize 
601 ± 61 
592 ± 97 
612 ± 64 
maltodextrin 
443 ± 46 
488 ± 62 
383 ± 65 
difference* 
155 ± 75' 
105 ± 110 
230 ± 9 0 " 
+
 The difference is corrected for the period effect. 
+ +
 Another 2 subjects had provided insufficient sample for hydrogen analysis. 
' p = 0.03" p = 0.02 
Methane excretion. 
The mean concentration of methane in ambient air was 3.9 ± 1 . 2 
ppm. During amylomaize supplementation, the mean methane 
concentration in breath, corrected for ambient air concentration, 
ranged from 17 to 26 ppm in methane excreters (figure 2). The area 
under the curve of concentration versus time was significantly higher 
during amylomaize supplementation than during control treatment 
(table 4). 
In subjects initially classified as 'non-methane producers", methane 
excretion was indeed negligible on either treatment (table 4). 
104 Chapter 7 
E 
α. 
о. 
σι 
о 
40 
30 
2 0 . : 
10 
τ/" 
< 
ι/ 
\^.У1 ι 1 
°r
 Α 
• RESISTANT STARCH 
О MALTODEXTRIN 
0800 1200 1600 2000 0000 0400 0800 
Time (hr) 
Figure 1. Mean breath hydrogen concentration on the seventh day of 
supplementation of a normal Dutch diet with 3 χ 15 g per day of maltodextrin or 
of native amylomaize (Hylon-VII), providing 28 g/d of type II resistant starch. Bars 
indicate one standard error of the mean. ІЩ^ : time of ingestion of supplement). 
40 
E 30 
α> 
с 
α £ 20 
о S 
я 
α> 
ш 10 
• RESISTANT STARCH 
Ο MALTODEXTRIN 
Τ 
- · — · . 
\ 
„ο ο-
1 ϊ " — £ — 2 " — χ 1 
Ι Ι Ι Ι 
_| ι 
0800 1200 1600 2000 0000 0400 ΟΘ00 
Time (hr) 
Figure 2. Mean breath methane concentration of 11 methane producing subjects 
on the seventh day of supplementation of a normal Dutch diet with 3 χ 15 g per 
day of maltodextrin or native amylomaize (Hylon-VII). Bars indicate one standard 
error of the mean. ІЩ^:ііте of ingestion of supplement). 
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Table 4. Mean 24-hour integrated breath methane excretion (ppm ж 
hr) ± SEM of healthy subjects on the final of 7 days of supplementa­
tion with 45 g/d of native amylomaize (Hylon-VII) or maltodextrin. 
N amylomaize maltodextrin difference + 
Methane excreters 11 506 ± 109 280 ± 73 247 ± 1 1 9 ' 
Non-methane excreters 8 1 ± 1 4 ± 3 - 3 ± 3 
+
 The difference is corrected for the period effect. 
' ρ = 0.03. 
/-/¿-equivalents in methane producing subjects. 
In subjects who produce methane, hydrogen formed by fermentation 
is converted into methane according to the equation: 4H2 + C02 — > 
CH4 + 2H20 2 \ The primary 24 hour integrated hydrogen production 
in such subjects (H2-equivalent) was estimated according the formula: 
area under the curve |H2) + 4x area under the curve (CH4). This sum 
rose significantly in methane producing subjects from 1607 ± 283 
ppm χ hr during placebo supplementation to 2617 ± 4 1 9 ppm χ hr 
during resistant starch supplementation. After correction for a period 
effect, the difference between the two supplementations was 1094 
± 447 (p = 0.015). 
Discussion. 
Data about hydrogen excretion after resistant starch ingestion are 
scarce. A positive response has been demonstrated after single doses 
of raw potato starch 24 and raw banana starch 2 5, and consumption of 
a type III resistant starch as cornflakes resulted in an elevation of 
breath hydrogen on the first day of consumption 2 e. However, several 
studies have demonstrated an adaptation of the colonic flora after 
chronic consumption of fermentable substrate 2 7 , 2 8. Therefore, the 
increased fermentation after continued resistant starch consumption 
found in this study is more relevant to real-life situations than the 
effect of a single dose. Studies concerning hydrogen excretion after 
fiber ingestion have shown conflicting results 4-29'30, which could 
partly be explained by differences in fermentability of different fibers. 
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As hydrogen is produced by bacterial fermentation in the colon, the 
rise of hydrogen excretion is probably the result of fermentation of 
amylomaize escaping digestion and absorption in the small bowel. 
Hydrogen excreted during the maltodextrin period is the result of 
background fermentation of other food constituents in the normal 
diet. This integrated hydrogen excretion during the placebo supple­
mentation was similar to that reported by other authors *. Hydrogen 
produced in the large bowel may be further metabolized to acetate by 
acetogenic bacteria, to H2S by sulphate reducing bacteria, or to 
methane by methanogenic bacteria 1θ. Competition between these 
metabolic pathways exists, and only half of the western population 
shows significant excretion of methane 17. In the present study, 
methane excreting subjects showed a significant increase of methane 
excretion after resistant starch supplementation. Flourie et al found 
that a large increase in the intake of digestible starch also resulted in 
an increased excretion of methane, but not of hydrogen 14. Presuma­
bly, an overload of digestible starch results in a partial escape from 
small bowel digestion and to colonic fermentation. Studies about the 
effect of fiber consumption on methane excretion have shown 
conflicting results 31"34, although in general the effect is minimal. This 
suggests that resistant starch may more readily increase colonic 
fermentation than does dietary fiber. 
Those of our subjects who did not excrete methane when on their 
regular diets also did not do so after resistant starch supplementation. 
A lack of excretion of methane thus appears to be due to a difference 
in colonic bacterial composition rather than to a lack of fermentable 
substrate in the habitual diet. 
Hydrogen excretion did not increase significantly in the methane 
excreting subjects after supplementation of resistant starch. We 
speculate that this is due to excess hydrogen being channelled into 
methane production. Formation of one molecule of methane requires 
four molecules of hydrogen. The equivalent H2 excretion, calculated 
as H2 -I- 4CH4, rose significantly in methane producers after resistant 
starch consumption. This suggests that the difference in response of 
breath hydrogen to resistant starch between methane and non-
methane-excreting subjects was due to a difference in utilization of 
the hydrogen produced, rather than to a difference in colonic 
production of hydrogen from resistant starch. In a previous study 
using whole body calorimetry, lactulose consumption caused a lower 
In-vivo fermentation of resistant starch 107 
hydrogen excretion but a higher excretion of total H2-equivalents in 
methane producers than in non-methane-excreting subjects 25. This is 
in line with our results. 
The relatively large amount of resistant starch (28 g/d) given by us 
was well tolerated; the subjects reported an increase in flatulence but 
no other discomfort or symptoms. 
We conclude that a supplementation of the diet of healthy volunteers 
with 28 g/d of type II resistant starch in the form of 45 g/d of native 
amylomaize is well tolerated, and results in an increased colonic 
fermentation. Epidemiological studies are warranted to elucidate a 
possible protective effect of resistant starch on the development of 
colon cancer. 
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Abstract. 
Background: Resistant starch is by definition that part of starch that 
escapes digestion in the small bowel. Cecal fermentation of resistant 
starch into short chain fatty acids will result subsequently in a 
decrease in pH. Thus, resistant starch may have the same effect on 
colonic luminal contents and mucosa as some fiber components. 
Methods: We studied the effects of adding 45 g native amylomaize 
(Hylon-VII) to a standardized diet in 14 healthy volunteers on fermen-
tation and colonic mucosal proliferation. Hylon-VII is a high amylose 
maize starch, containing 62% resistant starch. 
Results: During amylomaize consumption, breath hydrogen excretion 
raised with 85% and fecal short chain fatty acid output increased 
with 35% (p<0.01). Excretion of primary bile acids increased and the 
soluble deoxycholic acid concentration decreased by 50% 
(p = 0.002). Subsequently, cytotoxicity of the aqueous phase of feces 
-as measured on a colon cancer cell line- decreased (p = 0.007). 
Colonic mucosal proliferation in rectal biopsies (Proliferating Cell 
Nuclear Antigen immunostaining) decreased from 6.7 to 5.4% 
(p = 0.05). We speculate that resistant starch consumption decreases 
the colonic mucosal proliferation as a result of the decreased 
formation of cytotoxic secondary bile acids, which is possibly 
mediated through acidification of the large bowel by production of 
short chain fatty acids. 
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Introduction 
Fermentation of fiber to short chain fatty acids (SCFA) in the colon 
has been postulated to be one of the factors that protect the mucosa 
against malignant transformation. In man, low fecal butyrate 
concentrations have been associated with an increased risk for the 
development of colonic neoplasms 1 3 . Cancer cell experiments have 
shown that butyrate has antineoplastic characteristics. It promotes 
cell differentiation and reduces the growth rate of cultured cells by 
decreasing the doubling time 4'5. Besides a direct effect of butyrate on 
cellular proliferation and differentiation, production of SCFA also 
lowers the colonic pH. This results in inhibition of bacterial transform­
ation of primary into secondary bile acids e'7 and in a decreased 
solubility of these acids e. Secondary bile acids are cytotoxic to 
colonic ceils, subsequently resulting in an increased cell proliferation9. 
An increased cell proliferation is associated with a higher susceptibil­
ity for the development of colonic cancer 10"12. The fraction of S-
phase cells is increased in a hyperproliferative mucosa. Subsequently, 
mutagenic substances that are present in the colon, can exert more 
effect because the number of "target cells" ( S-phase cells) is 
increased. This mechanism could explain the demonstrated (co-) 
carcinogenicity of bile acids 13"15. 
Several epidemiological studies have shown a protective effect of 
dietary fiber on the development of colonic cancer, although this is 
not a consistent finding 1 θ 2 0. The interpretation of the relation 
between fiber and colonic cancer risk is complicated by the fact that 
different types of fiber can have different effects 21"23. Fermentation 
of components of fiber could contribute to a diminished risk, as could 
accelaration of transit time and dilution. On the other hand, 
gelforming types of fiber could bind bile acids and increase the 
colonic bile acid load. In a recent meta-analysis, it has been shown 
that fiber derived from vegetables, fruit or cereals can have a different 
protective effect on colon cancer formation 24. It is yet unclear to 
what extent the difference in fermentability of types of fiber 
contributes to these differences. 
Resistant starch (RS) is also a potential source of fermentable 
substrate, resulting in SCFA production. RS is defined as starch 
escaping digestion in the small bowel 2 5 2 ? and can be classified in 3 
groups 2 5: type I or RS,, representing physically inaccessible starch 
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like whole or partly milled grains; type II or RS2, representing starch in 
granules, like raw potato, unripe bananas; and type III or RS3, 
representing retrograded amylose starch. Native Hylon-VII, a high 
amylose maize starch, is an example of a type II resistant starch. 
Assuming that fermentation contributes to a lower colon cancer risk, 
resistant starch might be an attractive substance in dietary 
intervention studies. However, only few data on fermentation of RS 
in the human large intestine are available. In two previous studies 
about the relation between starch fermentation and colonic cancer 
risk, conflicting results have been found 28,29. The effect of RS on bile 
acid metabolism and colonic proliferation in humans has not been 
investigated to our knowledge. We therefore have studied in a pilot 
experiment the effects of supplementation of native amylomaize to a 
standardized diet of healthy volunteers on colonic fermentation, bile 
acid metabolism, cytotoxicity of fecal water and colonic mucosal 
proliferation. 
Materials and methods 
Outline of the study. 
Fourteen healthy volunteers (9M, 5F, age 28-73 years) participated in 
a 3 week study. The average weight of the volunteers was 77.7 ± 
2.0 kg and did not change during the experiment. A short outline of 
the study is given in figure 1. A dietary history was taken by a 
dietician, and the volunteers were instructed to take an average 
Dutch diet containing approximately 20 g natural fiber and 120 g fat 
of which 60% was unsaturated. Only minor modifications of the 
habitual diets of the volunteers were necessary. In the second and 
third week of the study, a daily dose of 3x15 gr native, uncooked 
amylomaize (Hylon-VII) was added to the diet. Hylon-VII (National 
Starch & Chemical Company, Zutphen, The Netherlands) is a high 
amylose maize starch, containing about 62% of type II resistant 
starch, as determined by the in vitro method of Englyst et al. 30. At 
the end of the first week of the study, during which the volunteers 
were on the standardized diet (control period), and at the end of the 
third week, while the diets were supplemented with amylomaize for 
two weeks (experimental period), rectal biopsies were taken, without 
previous taxation. In these biopsies, colonic cell proliferation was 
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determined. At the end of the control and experimental periods, the 
72 hour fecal output was collected on dry ice for determination of 
starch content, short chain fatty acids, total and aqueous phase bile 
acid concentrations and cytotoxicity of fecal water. Furthermore, 
breath samples were taken at the end of the first week, 2 days after 
the start of amylomaize supplementation and at the end of the third 
week for determination of hydrogen concentrations. 
The study was approved by the Ethical Committee of the University 
Hospital Nijmegen. 
day I 7 14 21 
Native amylomaize 
Fecal sampling 
Breath sampling 
Rectal biopsy 
Figure 1. Design of the study. During week 2 and 3, subjects received 45 g/d of 
amylomaize. 
Dietary diary for food composition. 
To check for dietary compliance, during the last 4 days of the control 
period and of the experimental period, all participants recorded the 
total amount of food intake in a dietary diary. From these diaries, diet 
composition was calculated using the 1987 release of the 
Netherlands nutrient data bank. 
Breath hydrogen measurement. 
Breath samples were collected in 60 ml syringes at 2 hr intervals from 
8.00 am until 24.00 hr and at 8.00 pm the next morning. Within 24 
hour, hydrogen concentrations were measured employing a standard 
electrochemical cell (Lactoscreen, Hoekloos, Amsterdam, The 
Netherlands). Previously, we found that the hydrogen concentration 
did not decrease during 48 hr storage (unpublished results). The 
hydrogen excretion was expressed as area under the concentration-
time curve (AUC). The percentual increase in hydrogen excretion in 
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the experimental period compared to the control period was 
calculated. 
Preparation of the aqueous fraction of stool. 
Stool samples were collected on dry ice and subsequently stored at -
20°C until processing. Samples were homogenized with a blender 
and ultracentrifugated at 30.000 g for 2 hr at 4°C. Fecal water (FW) 
was carefully removed and filtered employing a 0.2// filter, ( 
Schleicher & Schuell, Dassel, Germany) and stored at -20 °C until 
analysis. 
Short chain fatty acid analysis. 
Ten μ\ of a solution of 0.17 M 2-ethylbutyric acid (internal standard) 
in 100% formic acid was added to 100 μ\ of fecal water. The mixture 
was centrifugated and 0.7 μ\ of the resulting clear supernatant was 
directly injected in a Packard gas Chromatograph (column: 10% 
SP1200 / 1 % H3P04 on 80/100 Chromosorb WAW). The injection 
port of the Chromatograph was installed with an 8 cm long glass liner 
with an internal diameter of 3 mm, stoppered with a glass wool plug. 
Injection was performed in the space inside the liner above the glass 
wool plug. Details of the gas-chromatographic separation of SCFA 
have been described elsewhere 31. 
Bile acid analysis. 
Bile acids were determined as published before 3 2 , 3 3, with slight 
modifications. After enzymatic hydrolysis the bile acids were 
extracted from fecal water (0.5 ml) by SepPak C18 chromatography. 
The saponifiable conjugates were then hydrolyzed at 60°C for 2 h in 
1 ml of 1 M КОН in methanol. The unconjugated bile acids were 
separated from the neutral sterols by Lipidex DEAP chromatography 
and measured after methylation and silylation by capillary gas 
chromatography (column CP Sil 5CB) on a Packard 430 gas 
Chromatograph. 
Residual starch in stool. 
The amount of residual starch present in the feces was determined 
according Björck et al 34. Shortly, 50 mgr freeze dried feces was 
suspended in 2 ml water and free glucose was measured after heating 
(5min, 100 °C). To measure the total glucose, which is the sum of 
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starch and free glucose, 50 mgr freeze dried feces were suspended in 
1 ml water and 1 ml 4 M КОН and incubated during 30 min at RT. 
The suspension was neutralized with HCL and 1 +1 diluted with Na-
acetate buffer (0.4 M, pH 4.75). The mixture was incubated with 20 
μ\ amyloglucosidase (1gr/100ml, Boehringer) during 30 min, at 60°C. 
Total glucose was determined in the supernatant. The amount of 
starch is the difference between total glucose and free glucose. 
Cytotoxicity assay with HT-29 cells. 
We used a colonic cancer cell-line, HT-29, to measure cytotoxicity 35. 
Cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM, 
Flow Laboratories Irvine, Scotland) until 90% confluence. After 
trypsinization, cells were resuspended and plated in 96 multi well 
plates ( Costar, Cambridge, Mass, USA) with a concentration of 
15.000 cells/well. After 48 hours culture at 37°C under 5% C02, 
cells were washed and incubated for 1 hour with 100 μ\ fecal water. 
Every experiment with a single fecal water sample was performed in 
octuple. After 1 hour incubation, cells were washed and cultured for 
another 48 hours with DMEM. Then 20 μ\ of a 1 mg/ml 3-(4,5,-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide solution (Sigma 
St. Louis, MO, USA) was added to every well. In the viable cells, the 
tetrazolium salt will be converted by mitochondrial activity to 
formazan, a blue dye 3 β 3 θ . After four hours cells were washed and 
lysis was carried out with 100//I dimethylsulfoxide to free the formed 
formazan. Absorption was read at 545 nm using a Multiscan (Titertek 
Multiskan, Flow, Helsinki, Finland). The cell survival was expressed as 
percentage absorption of the maximal absorption, read from the wells 
incubated with PBS. Cytotoxicity is inverse correlated with the 
percentage survival (100 - survival). 
PCNA proliferation in rectal biopsies. 
Three rectal biopsies were fixed in 70% ethanol for Proliferating Cell 
Nuclear Antigen immunostaining. Standard histological sections were 
prepared on poly-L-Lysine (Sigma) coated slides. After deparaffi-
nization and blocking of endogeneous peroxidase, sections were incu­
bated with PC10 antibodies in a 1:400 dilution for 1 hr at 25°C 
(Dako, Glostrup, Denmark). After washing, a streptavidine-biotine 
system (Histostain-SP, Zymed Laboratories, San Francisco, USA) was 
used to visualize the anti-body. Sections were microscopically 
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examined under code with a 40x objective, at least 10 completely 
longitudinally sectioned crypts were scored and the mean value was 
calculated. All cells with a homogeneous and distinct red nucleus 
were counted as positive. The fraction positive cells in the whole 
crypt was calculated, as well as in 5 crypt-segments, from the basal 
to the luminal side of the crypt. 
Statistics. 
Results are expressed as mean ± SEM. The averages of each test 
during the control and experimental period were compared, using a 
Wilcoxon signed rank test, the two tailed P-value for normal 
approximation is given. For Hydrogen and SCFA changes, the one 
tailed P-value is given. 
Results. 
One volunteer dropped out of the study because of abdominal cramps 
and discomfort after starting with the amylomaize. The other 13 
participants tolerated the amylomaize well. The relevant part of food 
composition data is given in table 1. 
Table 1. Food composition data of 13 subjects during the control 
period and during supplementation of 45 g/d Amylomaize. 
Energy (Kcal/day) 
Fat (g/day) 
Fat (energy %) 
Sat. Fat (%) 
Starch (g/day) 
Fiber (g/day) 
Calcium (mg/day) 
Control 
period 
2427 ± 1 1 6 
123 ± 6 
45 ± 1 
39 ± 2 
124 ± 7 
17 ± 1 
953 ± 94 
Native amylomaize 
supplementation 
2462 ± 128 
125 ± 8 
46 ± 1 
40 ± 4 
121 ± 9 
16 ± 1 
1024 ± 142 
Values are given as mean ± SEM. In addition, subjects received 45 g/d of amylo-
maize during the experimental period. None of the differences is significant. 
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No significant changes were found between the control period (week 
1 ) and the experimental period (week 3), so we assume the food 
intake did not influence other parameters studied. 
Fermentation. 
The stool consistency and bowel frequency did not change 
significantly. The mean wet weight of the daily stool increased by 
2 3 % (p = 0.04), the mean percentage dry matter did not change (25 
vs 2 4 % ) , nor did the fecal pH (table 2). 
The integrated hydrogen excretion increased from 101 ± 19 ppm.hr 
during the control period to 186 ± 38 ppm.hr on the second day of 
the experimental period ( 8 5 % , ρ = 0.002) and was still increased at 
the end of the experimental pariod (44%, ρ = 0.03). The fecal SCFA 
excretion increased from 7.1 to 9.6 mmol/day (fig. 2). This increase 
was mainly caused by a 3 5 % rise in acetate and a 4 7 % rise in 
butyrate excretion. Excretion of total SCFA's and of acetate and 
butyrate were significantly higher during amylomaize suppletion 
(p = 0.005). 
No significant changes were found in the fecal concentrations of 
SCFA's. The total SCFA concentration varied from 87.8 ± 1 0 . 5 mM in 
the control period to 89.6 ± 1 0 . 5 mM in the experimental period, 
acetate from 55.3 ± 3.6 to 56.6 ± 3.6 mM, propionate from 1 5.5 ± 0 . 9 
to 1 5 . 2 ± 0 . 9 mM and butyrate from 9.1 ± 1 . 1 to 1 0 . 4 ± 1 . 5 m M . 
Table 2. Fermentation data of 13 subjects during the control period 
and during supplementation of 45 g/d native amylomaize. 
Control 
period 
119 ± 9 
6.6 
101 ± 19 
7.1 ± 0.8 
0.10 ± 0.03 
Native amylomaize 
supplementation 
147 ± 10 
6.7 
186 ± 38 
144 ± 19 
9.6 ± 1.4 
0.26 ± 0.08 
Ρ 
0.04 
η.s. 
0.002 
0.03 
0.005 
η.s. 
Values are given as mean ± SEM. 
Stool weight (gr/day) 
Stool pH 
Hydrogen excretion (ppm.hr) 
day 2 supplementation 
day 14 supplementation 
SCFA excretion (mmol/day) 
Residual starch (gr/day) 
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Figure 2. Fecal excretion (24 hour) of acetic, propionic, butyric and valeric acid 
(mean ± SEM) during control and experimental period. 
' ρ < 0.05 and " ρ < 0.005, compared with control period. 
In the control period, 0.1 ± 0.03 g/day of residual starch was found 
in the feces. During the experimental period, with a daily suppletion 
of 45 gr amylomaize, the residual starch content rose to 0.26 ± 0.08 
mg/day. This points to an almost complete fermentation of 
amylomaize. 
Fecal bile acids. 
The concentrations of total bile acids (in freeze dried feces) are given 
in table 3. The primary bile acid concentration rose from 1.5 to 3.9 
/лтюі/дг dry weight (p = 0.03). The concentration of secondary bile 
acids tended to decrease from 25.3 to 20.4 //mol/gr dry weight 
(p = 0.08), and the fraction secondary bile acids decreased from 93% 
to 82% (p = 0.02). 
In the aqueous phase of stool the concentration of total soluble bile 
acids decreased from 177.0 to 99.8 //mol/l (p = 0.004). The 
deoxycholic acid concentration decreased by 49.8% (from 78.0 to 
39.2 //mol/l, p = 0.002) (Figure 3). 
H 
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Figure 3. Concentration of bile acids in the aqueous phase of stool during control 
and experimental period (mean ± SEM). The soluble DCA concentration decreased 
with 49% (p = 0.002). DCA: deoxycholic acid; LCA: lithocholic acid; CDCA cheno-
deoxycholic acid; CA: cholic acid. 
Cytotoxicity of the aqueous phase of stool. 
In the cytotoxicity assay, all but one of the volunteers demonstrated a 
decrease in the cytotoxic potential of the FW (fig 4). The mean 
cytotoxicity decreased from 84 ± 6% to 72 ± 9% (p = 0.007). 
Colonic mucosal proliferation. 
Biopsies from one volunteer did not show sufficient intact crypts to 
score. Proliferation of colonic crypt cells in the other 12 subjects was 
determined in the total crypt and in 5 different crypt segments. An 
example of PCNA labelled crypts is given in figure 6. A decrease in 
proliferation was found (fig. 5), the total labelling index decreased 
from 6.7 ± 1.7 to 5.4 ± 1.1 % (p = 0.05). Since in those healthy 
volunteers almost no labelling was observed in the upper 
compartments, the decrease in proliferative activity could mainly be 
attributed to the 3 basal compartments. 
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Figure 4. Cytotoxicity of individual 
fecal water samples as determined 
with the HT-29 assay. During the 
native amylomaize supplementation 
the mean cytotoxicity decreased from 
84 to 71 % (p =0.007). 
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Figure 5. PCNA labelling index of 
colonic mucosa in 12 subjects before 
and during the amylomaize 
supplementation. The mean labelling 
index decreased from 6.7 ± 1.7 to 
5.4 ± 1.1 % (p = 0.05). 
Discussion. 
This study shows important changes in fecal bile acid composition 
and colonic cell proliferation during the supplementation of resistant 
starch to a normal Dutch diet. Because no changes were observed in 
food composition during the study, we assume that the changes were 
caused by the resistant starch supplementation. The almost complete 
absence of residual starch in the feces points to a complete utilisation 
of the starch in the large bowel. 
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Figure 6. Immunostaining of colonic mucosal crypts with a PCNA-antibody. 
The increased hydrogen excretion was the result of fermentation of 
resistant starch. The more marked hydrogen excretion in the first 
days after amylomaize supplementation compared to the end of the 
study period, is suggestive of a certain degree of adaptation which 
has been described previously 39,4°. 
The rise in SCFA excretion was relatively minor, but we assume that 
this is the result of the efficient absorption and utilisation of SCFA's 
in the large bowel 41"43. The increase of the butyrate excretion during 
RS is of special interest, because differentiating and anti-neoplastic 
effects have been demonstrated in vitro 5 · 4 4 4 β . The relative enrichment 
of butyrate in the SCFA pool after starch or RS fermentation has been 
demonstrated recently 4 7 , 4 8. 
Non-digested starch will be fermented after entering the cecum 4 9, 
resulting in a lower pH in this part of the large bowel. It has been 
demonstrated that the pH of the colonic contents gradually rises 
during the transport from cecum to sigmoid 42,5°. This is probably due 
to the absorption of SCFA's. Thus fecal pH is not necessarily a good 
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indicator for fermentation and acidity in the proximal colon, and this 
may be the explanation for the absence of change of the fecal pH. 
We have studied the effect of RS fermentation on soluble and total 
fecal bile acids. Most important, to our opinion, is the bile acid 
composition of the aqueous phase of stool, because only the soluble 
bile acids are in contact with the colonic mucosa and can cause 
mucosal damage 8. Precipitation or binding of bile acids, resulting in a 
shift from the "soluble" compartment to the inert, "solid" compart-
ment is reflected in the bile acid concentrations in the total freeze 
dried feces 51. Therefore, changes in total and soluble bile acid com-
position have to be considered separately, and to our opinion the 
50% reduction of the soluble DCA concentration is the most 
important change. 
A decrease in the pH in the proximal colon can have two sepárete 
effects on bile acid metabolism. Firstly, the bacterial conversion of 
primary bile acids into secondary bile acids is inhibited at a pH value 
below 6 θ. Formation of secondary bile acids primarily occurs in the 
cecum. In animal studies it has been shown that cecectomy abolishes 
secondary bile acid formation 5 2 , 5 3. The inhibition of bacterial con­
version may explain the decrease in the total secondary bile acid 
concentration and in soluble DCA. It does not explain why the 
amount of soluble primary bile acids did not increase. Secondly, it 
seems likely that acidification of the colonic contents by RS fermenta­
tion leads to precipitation of unconjugated bile acids (pKa's around 
5.0) 54. This results in a shift of soluble bile acids to the insoluble 
fraction. Bacterial conversion of primary bile acids is thus inhibited, 
resulting in an important decrease in soluble DCA and to an increase 
of the total primary bile acid concentration. Precipitation of bile acids 
has been demonstrated in rats in whom an important decrease of 
cytotoxicity and mucosal damage has been shown after lowering the 
pH in the large bowel from 7.9 to 5.5 8. 
Previously, a shift towards a more fermentation-prone diet resulted in 
a 4 1 % decrease of soluble DCA 5S, which is in line with the data we 
present in our study. Studies about the effect of fiber on bile acid 
metabolism have shown controversial results 22,23. In general, wheat 
bran causes a decrease of the biliary DCA fraction and total fecal 
DCA concentration, but pectin showed opposite results. 
One should suspect that the effects of amylomaize on bile acid 
metabolism show a certain similarity with the effects of lactulose, a 
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non-absorbable disaccharide, which is rapidly fermented in the 
cecum. Indeed, several studies have shown a decrease in DCA 
formation and poolsize after lactulose consumption 7·56·57. To our 
knowledge only one animal study about the effect of RS on bile acid 
metabolism has been published 5e. In this rat model, a decrease in 
cecal pH, an increase in SCFA and a decrease in the formation of 
secondary bile acids was demonstrated. The use of Acarbose (an a-
glucosidase inhibitor) causes starch malabsorption followed by 
fermentation in the large bowel, like RS. In a human study with 
Acarbose, stool weight increased and the excretion and concentration 
of both secondary bile acids decreased by approximately 50% 59. 
We speculate that the decrease in soluble DCA contributes to the 
reduction in fecal water cytotoxicity. We have found a significant 
correlation between soluble DCA concentration in FW and 
cytotoxicity35. Cytotoxicity of FW has been found to influence colonic 
proliferation 9. We speculate that the lower cytotoxicity of FW de­
creases colonic cell proliferation after amylomaize supplementation. 
This is of particular interest, as a low colonic proliferation is supposed 
to be associated with a reduced colon cancer risk. Whether the 
decreased colonic mucosal proliferation is caused by the increased 
SCFA formation due to the starch fermentation or by the decreased 
secondary bile acid concentration is not clear at this moment. Other 
hypotheses are possible to explain this effect of fermentation on 
proliferation. It has been speculated that an increased carbohydrate 
fermentation can reduce protein fermentation, resulting in a decreased 
formation of fecal carcinogens 0O. Only few data are available regard­
ing the effect of starch or fiber on colorectal cell proliferation. In 
humans, a decrease of rectal proliferation has been demonstrated 
after wheat bran suppletion 20. In animals, conflicting effects of starch 
or fiber suppletion on the colonic cell proliferation have been publis­
hed 4 β β 1 θ 2 . Long term, controlled dietary intervention studies are 
necessary to elucidate the possible protective effect of resistant 
starch on colonic cancer formation. 
In conclusion we have demonstrated that amylomaize is fermented in 
the colon, resulting in a decrease of soluble secondary bile acids, a 
decrease in the cytotoxicity of fecal water and a decrease of colonic 
mucosal proliferation. We assume that this study points towards a 
beneficial effect of resistant starch on several parameters, involved in 
colonic cancer risk. 
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In chapter I, the term resistant starch is introduced. It is defined as 
that part of starch and starch degradation products that escapes 
small bowel digestion in healthy individuals. It is speculated that 
resistant starch could be an attractive alternative for fiber in the 
prevention of colon cancer. 
In chapter II, the role of fermentation in the prevention of cancer of 
the large bowel is described. Resistant starch is probably a more 
important source of fermentable substrate than fiber. Short chain 
fatty acids are produced by fermentation of starch or fiber, resulting 
in a decrease in intraluminal pH. This acidic environment may 
decrease the concentration of soluble secondary bile acids by 
precipitation of bile acids and by diminishing bacterial transformation 
of primary bile acids. The promotion of colon cancer is probably 
mediated by the cytotoxic effect of secondary bile acids on mucosal 
cells, which results in increased cell proliferation. A hyperproliferative 
colonic mucosa has been demonstrated to be associated with an 
enhanced risk of colon cancer. 
In theory, stimulation of colonic fermentation will decrease the 
intracolonic pH, the soluble secondary bile acids and mucosal 
proliferation, thus possibly garding against colonic carcinogenesis. 
Studies and arguments that support this hypothesis are discussed. 
In chapter III, an overview of the literature is given concerning the 
effect of consumption of fiber on bile acid metabolism. It has been 
concluded that changes in deoxycholic acid kinetics and changes in 
deoxycholic acid concentration in the aqueous phase of feces are 
probably the most relevant parameters, however data on these topics 
are scarce. Bile acids are for 99% precipitated or bound to fecal bulk, 
and thus not in interaction with the colonic mucosa. Therefor, the 
total bile acid concentration in feces seems to be less relevant. 
Furthermore, the literature clearly illustrates that various fiber 
constituents can have different, and sometimes even counteracting, 
effects. 
In chapter IV, we describe a new method for measuring the cytotoxi-
city of bile acids. Cells from a colonic cancer cell-line (HT-29) were 
incubated with bile acid solutions and aqueous phase of stool, and 
the fraction of surviving cells was determined. This assay proved to 
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be more sensitive than the previously used erythrocyte-cytotoxicity 
assay. Chenodeoxycholic acid and deoxycholic acid were cytotoxic in 
concentrations above 100 ¿/mol/l, which is in the physiological 
concentration range of soluble bile acids in feces. 
Using this assay, the effects of calcium and calciumphosphate on bile 
acid cytotoxicity were studied. Previous investigations, using the 
erythrocyte model and bile acids in unphysiologically high concentrati-
ons, have demonstrated a decrease of cytotoxicity when calcium or 
calciumphosphate was added. At physiological concentrations, we 
could not find any evidence demonstrating that calcium or calcium-
phosphate offers protection against cytotoxicity caused by bile acids. 
Furthermore, the cytotoxicity of the aqueous phase of feces could be 
measured and, in fact, is significantly correlated to the concentration 
of deoxycholic acid. This finding suggests that soluble deoxycholic 
acid is indeed an important factor in mucosal injury. 
Since mucosal proliferation seems to be a biomarker to assess the 
risk of colon cancer, we have adapted an immunohistochemical 
method which stains proliferating cells with a antibody against 
Proliferating Cell Nuclear Antigen. This method is described in chapter 
V. Proliferating Cell Nuclear Antigen is a nuclear protein that is 
present in low concentrations during the entire cell cycle, and in high 
concentrations during late G2 and S-phases. Using a commercially 
available monoclonal antibody, it is possible to distingish proliferating 
cells. 
In a double labelling technique, we validated the immunostaining with 
an already established proliferation marker, 3H-Thymidine autoradio-
graphy. We found a sensitivity of 96% and a specificity of 98% for 
PCNA, and concluded that Proliferating Cell Nuclear Antigen immuno-
staining is a reliable method to assess colonic mucosal proliferation. 
The main advantage is that no special tissue preparation or incubation 
is necessary. 
In chapter VI, we studied the in vitro fermentation of amylomaize, a 
maize starch that contains 62% resistant starch. Amylomaize 
fermented more slowly than the disaccharide lactulose, but after 24 
hours, the total production of short chain fatty acids was the same. In 
methane producing fecal inocula, all hydrogen was converted to 
methane during the regular amylomaize fermentation. In contrast 
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during the more rapid lactulose fermentation, the production rate of 
hydrogen exceeded the rate of which methane forming bacteria could 
consume it, thus both hydrogen and methane were released in the 
first 4 hours of incubation. 
Fermentation in low methane producing inocula elapsed faster than in 
in high methane producers. Furthermore we found an increase of the 
butyrate fraction from 10 to 17% during fermentation of both, 
lactulose and amylomaize, compared to control incubations. 
In chapter VII, the results of a cross-over study are described, in 
which the normal diet of healthy volunteers was supplemented with 
45 g/d of amylomaize or placebo (maltodextrin) for 1 week, with a 
wash out period of 1 week between treatments. This dose of 
resistant starch was well tolerated; only a minor increase in flatulence 
was observed. The 24 hour integrated hydrogen excretion increased 
significantly in all subjects. In the methane excreting subjects, we 
found a significant increase in integrated methane excretion. 
We believe this increased hydrogen and methane excretion to be the 
result of stimulation of fermentation by amylomaize. 
In chapter VIII, we studied the effects of amylomaize supplementation 
on fecal weight, fermentation, bile acid metabolism, cytotoxicity of 
the aqueous phase of stool, and colonic mucosal proliferation. We 
therefore supplemented the standardized, normal Dutch diet from 
healthy volunteers with 45 g amylomaize per day. Breath samples, 3 
day fecal output, and rectal biopsies were collected before and at the 
end of the supplementation period. Fecal weight, 24 hour integrated 
hydrogen excretion, and fecal short chain fatty acid excretion 
increased, suggesting that amylomaize stimulated colonic fermentati-
on. The soluble deoxycholic acid concentration decreased by 50 % 
during amylomaize supplementation while the total primary bile acid 
concentration (in freeze dried feces) increased. This suggests inhibiti-
on of the conversion of primary into secondary bile acids, which is 
probably mediated by precipitation of primary bile acids. 
Furthermore, the cytotoxicity of the aqueous phase of stool as well as 
the colonic proliferation decreased significantly. 
In conlusion, we suggest that supplementation of the normal diet with 
resistant starch may have a positive effect on intermediate factors 
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that increase the risk of colon cancer. 
In summary we have demonstrated that amylomaize-resistant starch 
is well tolerated by healthy subjects and that in vitro as well in vivo 
fermentation is stimulated by this supplementation. Several factors, 
which are thought to be involved in colonic carcinogenesis, changed 
in a favourable way during amylomaize supplementation. Further long 
term studies are warranted to elucidate the possible protection that 
resistant starch can offer against colonic carcinogenesis. 
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Voeding en dikke darmkanker. 
Dikke darmkanker is de op één na meest voorkomende oorzaak van 
sterfte door kanker in de Westerse wereld. Over de oorzaken van 
dikke darmkanker is nog onvoldoende bekend. Het is wel duidelijk 
geworden dat bij een deel van de personen die dikke darmkanker 
krijgen erfelijke factoren een rol spelen, maar dat omgevingsfactoren 
meestal van veel meer invloed zijn. Dit is onder andere gebleken uit 
studies, waarbij mensen gevolgd werden nadat ze geëmigreerd waren 
van een land met een laag risico op dikke darmkanker naar een hoog-
risico gebied. Na verloop van tijd blijken deze emigranten hetzelfde 
risico te krijgen als de autochtone bevolking in hun nieuwe thuisland. 
Aangezien het milieu van de dikke darm bepaald wordt door wat we 
eten, wordt voeding beschouwd als de belangrijkste factor in het 
ontstaan van kanker in de dikke darm. Er zijn vele epidemiologische 
studies gedaan om te onderzoeken welke voedingsmiddelen nu 
daadwerkelijk schadelijk zijn en welke juist beschermend werken. Uit 
de meeste van deze studies blijkt dat de consumptie van veel vet het 
ontstaan van dikke darmkanker bevordert, terwijl het eten van veel 
vezels juist een beschermend effect heeft. Mogelijk heeft ook de 
consumptie van calcium een gunstige invloed. 
Voedingsvezels zijn bestanddelen afkomstig van planten, die niet door 
menselijke enzymen afgebroken kunnen worden. Deze vezels komen 
dus onverteerd in de dikke darm terecht, waar ze voor een deel door 
de daar aanwezige bacteriën wel afgebroken kunnen worden. Dit 
proces heet fermentatie. Voor een groot deel echter worden voedings-
vezels onveranderd met de ontlasting uitgescheiden. 
Het beschermend effect van vezels wordt grofweg aan twee 
mogelijke factoren toegeschreven. Op de eerste plaats is er een 
'mechanisch' effect. De in de dikke darm aanwezige vezels fungeren 
als bindmiddel of 'buikvormer', waardoor vele schadelijke en kanker-
verwekkende stoffen gebonden kunnen worden. Zij kunnen dan dus 
niet meer in contact komen met het dikke darmslijmvlies. Verder 
worden deze schadelijke stoffen door het grotere faecesvolume 
verdund. 
Op de tweede plaats is het mogelijk dat juist de fermentatie van 
vezels in de dikke darm verantwoordelijk is voor het beschermend 
effect. Bij die fermentatie ontstaan zogenaamde korte keten vetzuren, 
zuren die bestaan uit een keten van 2 tot 6 koolstofatomen. Deze 
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korte keten vetzuren zorgen voor een verlaging van de zuurgraad in 
de dikke darm, waardoor verschillende omzettingsprocessen anders 
gaan verlopen. Verder is van één van deze stoffen, namelijk boterzuur 
of butyraat, aangetoond dat het groeiremmende eigenschappen heeft 
en mogelijk ook eigenschappen, die de celrijping bevorderen (differen-
tiatie). Ook hierdoor zou het ontaarden van gezonde cellen in 
kankercellen tegengegaan kunnen worden. 
Of nu het 'bulkvormend effect' of juist de fermentatie van vezels de 
oorzaak is van het beschermend effect op het ontstaan van dikke 
darmkanker, is niet helemaal duidelijk. Onder andere vanwege de 
beschreven effecten van butyraat denken we dat de fermentatie-
factor wellicht het belangrijkst is. 
Om die reden hebben we een aantal studies gedaan met 'resistant 
starch', een voedingsmiddel dat, veel meer dan vezels, leidt tot 
toename van de fermentatie. Normaal wordt zetmeel in de dunne 
darm geheel afgebroken tot suikers, die daar opgenomen worden. 
Resistant starch is een speciaal soort zetmeel dat zodanig is opge-
bouwd dat het niet of slechts ten dele afgebroken kan worden in de 
dunne darm. Het grootste deel ervan komt dus in de dikke darm 
terecht, waar het - net als componenten van vezels - afgebroken 
wordt door bacteriële enzymen. Op deze manier kan de fermentatie 
sterk toenemen, mogelijk resulterend in een bescherming tegen dikke 
darmkanker. Aangezien dit resistant starch veel gemakkelijker in ons 
voedingspatroon is te integreren, zou het een veelbelovend alternatief 
kunnen zijn voor vezels in de preventie van dikke darmkanker. 
HOE ONTSTAAT DIKKE DARMKANKER ? 
Er is geen zekerheid over het exacte ontstaan van dikke darmkanker. 
Wel zijn er sterke aanwijzingen dat het proces begint met ver-
anderingen in de snelheid en in de plaats van celdeling in het dikke 
darmslijmvlies. Sterk uitvergroot ziet het slijmvlies er uit als een vlak 
oppervlak met talloze openingen, die leiden naar korte buisjes, lood-
recht op het oppervlak. In een dwarsdoorsnede ziet het slijmvlies er 
dus uit als een aaneenschakeling van buisjes, de cryptes. Op de 
bodem van deze cryptes vindt een continue celdeling plaats, waarna 
de nieuwe cellen als in een file geleidelijkaan naar boven toe ver-
huizen. Boven aangekomen worden ze losgelaten en verlaten ze het 
lichaam. 
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Onder invloed van genetische en omgevingsfactoren kan de celdeling 
versneld gaan verlopen en ook hogerop in de crypte plaats gaan 
vinden. Als men een dergelijke crypte in de lengte zou doorsnijden en 
bekijken, dan is het percentage delende cellen (de labellingsindex) 
toegenomen. Tevens zullen ook hogerop in de crypte nog delende 
cellen worden aangetroffen, in tegenstelling tot de normale situatie. 
De constante vernieuwing van crypte-cellen is noodzakelijk omdat 
deze aan vele beschadigende stoffen, die in de darm aanwezig zijn, 
blootstaan. Hoe sterker het celbeschadigend effect van de darmin-
houd (de cytotoxiciteit), des te groter zal het aantal kapotte cellen zijn 
en des te sneller zal de celdeling moeten zijn om deze te vervangen. 
Van galzouten is bekend dat ze cellen sterk beschadigen (cytotoxisch 
zijn) en verschillende studies hebben dan ook een relatie laten zien 
tussen galzouten en het ontstaan van dikke darmkanker. Galzouten 
worden in de lever gemaakt als de zogenaamde primaire galzouten. In 
de darm werken ze als zeep: ze verdelen het geconsumeerde vet in 
kleine partikeltjes, waardoor deze door enzymen beter en sneller 
afgebroken kunnen worden. Aan het einde van de dunne darm 
worden de meeste galzouten weer opgenomen in het bloed en naar de 
lever getransporteerd. Een deel van de galzouten ontsnapt echter aan 
deze opname en komt in de dikke darm terecht, waar ze door 
bacteriën worden omgezet in de secundaire galzouten lithocholzuur en 
deoxycholzuur. Vooral van deoxycholzuur wordt aangenomen dat het 
het ontstaan van dikke darmkanker kan stimuleren. Deze bacteriële 
omzetting is afhankelijk van de zuurgraad in de dikke darm en is 
geblokkeerd bij een lage zuurgraad. Verder is de oplosbaarheid van 
deze secundaire galzuren matig en eveneens afhankelijk van de 
zuurgraad: hoe zuurder hoe slechter oplosbaar. 
Als fermentatie een beschermend effect heeft op het ontstaan van 
dikke darmkanker, dan zou dat verklaard kunnen worden doordat de 
omzetting van primaire in -schadelijke- secundaire galzouten geremd 
wordt door de verlaging van de zuurgraad in de dikke darm als gevolg 
van de fermentatie. Tevens worden de gevormde galzouten in het 
zuurdere milieu neergeslagen, waardoor ze niet meer in contact 
kunnen komen met de crypte-cellen. Daarmee is ook hun schadelijke 
invloed afgenomen en zal de celdeling in de cryptes minder gestimu-
leerd worden. Dit alles zou kunnen resulteren in een kleinere kans op 
kwaadaardige ontaarding van het slijmvlies. 
144 Hoofdstuk 9 
DE OPZET VAN DIT PROEFSCHRIFT. 
De hypothese van dit proefschrift is dat een toename van de fermen-
tatie door consumptie van resistant starch zal leiden tot een vermin-
derde concentratie van opgeloste secundaire galzouten in de dikke 
darm en daardoor tot een vermindering van de cytotoxiciteit en tot 
een verlaging van snelheid van celdeling in de cryptes van de dikke 
darm. In hoofdstuk 2 en 3 wordt een uitgebreid overzicht gegeven 
van de literatuurgegevens die deze hypothese ondersteunen. 
Eerst werd een methode ontwikkeld om snel en reproduceerbaar de 
cytotoxiciteit van darminhoud en galzouten te kunnen meten (hoofd-
stuk 4). Vervolgens wordt een methode beschreven en getoetst om 
delende cellen in een darmcrypte aan te kleuren met behulp van 
antistoffen tegen het PCNA, een eiwit dat in delende cellen in grote 
mate aanwezig is (hoofdstuk 5). 
Vervolgens wordt in hoofdstuk 6 beschreven hoe het door ons 
gebruikte resistant starch (amylomaize) door dikke darmbacteriën 
afgebroken wordt. 
In het volgende hoofdstuk wordt het effect beschreven van consump-
tie van 45 gr resistant starch per dag op de fermentatie bij 19 
gezonde vrijwilligers. 
In de laatste studie (hoofdstuk 8) wordt wederom 45 gr resistant 
starch gegeven aan 13 gezonde vrijwilligers. Daarbij werd niet alleen 
naar het effect op fermentatie gekeken, maar ook naar het effect op 
secundaire galzouten, op cytotoxiciteit van de faeces en op de 
delingssnelheid in de darmcryptes. 
METING VAN DE CYTOTOXICITEIT. 
In hoofdstuk 4 wordt een nieuwe methode beschreven die ontwikkeld 
is om het cytotoxisch effect van galzuren te meten. Hierbij werden 
aan een kweek van colonkankercellen verschillende galzuurop-
lossingen toegevoegd, met een oplopende concentratie, waarna het 
percentage overlevende cellen werd gemeten. Dezelfde experimenten 
werden uitgevoerd met de waterige fractie van menselijke faeces, 
waarin onder meer de opgeloste galzouten uit de ontlasting aanwezig 
zijn. Deze methode blijkt veel gevoeliger om de cytotoxiciteit te meten 
dan een door andere onderzoekers gebruikte methode met rode bloed-
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cellen. De galzouten Na-Chenodeoxycholzuur en Na-deoxycholzuur 
zijn cytotoxisch in concentraties vanaf 100 //mol/l, hetgeen in de orde 
van grootte ligt van de deoxycholzuur-concentratie die in opgeloste 
vorm in menselijke ontlasting gevonden wordt. 
Tevens werd met deze methode het effect van calcium en calciumfos-
faat op de cytotoxiciteit van galzuren onderzocht. In vroegere studies 
vond men dat toevoegen van calcium of calciumfosfaat aan (onfysio-
logisch) hoge concentraties galzuren een daling van de cytotoxiciteit 
liet zien. Bij gebruik van lage concentraties galzuren, zoals die 
voorkomen in opgeloste vorm in faeces, konden wij geen bescher-
mend effect van deze stoffen vaststellen. 
Tenslotte werd met deze methode de cytotoxiciteit gemeten van 
faecaal water. Dat is het water in de ontlasting, waarin alle opgeloste 
stoffen aanwezig zijn; dit in tegenstelling tot de vaste massa, waarin 
alle gebonden en neergeslagen bestanddelen aanwezig zijn. Men 
neemt aan dat het faecaal water erg belangrijk is, omdat daarin de 
stoffen aanwezig zijn, die in contact komen met de slijmvliescellen. 
De cytotoxiciteit van faecaal water bleek significant gecorreleerd met 
de concentratie opgelost deoxycholzuur. Dit geeft steun aan de 
hypothese dat deoxycholzuur een belangrijke rol speelt bij de 
beschadiging van het dikke darmslijmvlies. 
METING VAN CELDELING MET BEHULP VAN PCNA. 
In hoofdstuk 5 wordt een methode beschreven die gebruikt kan 
worden om de celdeling in het dikke darmslijmvlies te meten. Hierbij 
werd met een commercieel verkrijgbare antistof een eiwit aange-
toond, dat aanwezig is in delende (prolifererende) cellen. Dit eiwit 
heet 'Proliferating Cell Nuclear Antigen', afgekort tot PCNA. PCNA is 
met name aantoonbaar in de late G2-fase en in de S-fase van de cel-
cyclus, dat is de periode dat de cel in deling is. Deze methode werd 
tegelijkertijd gebruikt met de 3H-Thymidine methode. Dat is de 
'gouden standaard' methode om delende cellen aan te tonen, door 
aan weefsel radioactieve DNA-bouwstenen toe te voegen, die in de 
delende cellen ingebouwd worden en later weer zichtbaar te maken 
zijn. In dit experiment hebben we beide methoden toegepast op 
dezelfde stukjes dikke darmslijmvlies en gekeken in hoeverre met de 
PCNA-methode dezelfde cellen aangetoond werden als met de 3H-
Thymidine methode. 
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Hierbij vonden wij een sensitiviteit van 96% en een specificiteit van 
98%, waaruit geconcludeerd mag worden dat PCNA-kleuring een 
goede methode is om de delingsactiviteit van het dikke darmslijmvlies 
vast te stellen. Het belangrijkste voordeel van de PCNA-methode is 
dat de cellen direct gekleurd kunnen worden, zonder voorbehandeling 
met b.v. radioactieve bestanddelen. 
FERMENTATIE VAN AMYLOMAIZE. 
Vervolgens wordt in hoofdstuk 6 onderzocht hoe amylomaize 
gefermenteerd kan worden. Amylomaize is een speciaal soort zetmeel 
dat voor 62% bestaat uit resistant starch, zetmeel dat niet in de 
dunne darm verteerd en opgenomen kan worden. Amylomaize werd in 
een proefopstelling samen met bacteriën uit de dikke darm in een 
kweekflesje gemengd, vervolgens werd gekeken hoe snel de afbraak 
verliep en wat voor stoffen geproduceerd werden. Dit werd vergele-
ken met een andere fermenteerbare stof namelijk lactulose. 
Daarbij bleek dat de afbraak van amylomaize langzamer verloopt, 
maar dat de uiteindelijke opbrengst aan korte keten vetzuren vergelijk-
baar is. Bij fermentatie van amylomaize en lactulose werd niet alleen 
een grotere hoeveelheid korte keten vetzuren geproduceerd, ook het 
relatieve aandeel van butyraat hierin bleek duidelijk toe te nemen. Dit 
lijkt van belang omdat aan butyraat een belangrijke regulerende 
functie bij de celdeling en mogelijk ook beschermende eigenschappen 
tegen de ontwikkeling van dikke darmkanker toegekend worden. 
CONSUMPTIE VAN RESISTANT STARCH DOOR PROEFPERSONEN. 
Daarna wordt in hoofdstuk 7 onderzocht of amylomaize ook in 
werkelijkheid leidt tot een toename van de fermentatie. Tijdens 
fermentatie ontstaat waterstof en bij een deel van de mensen ook 
methaan. Beide gassen worden in het bloed opgenomen en vervol-
gens via de longen uitgeademd. De hoeveelheid in de uitademings-
lucht is dus een maat voor de fermentatie. 
In deze studie werd aan de normale voeding van 19 gezonde 
vrijwilligers gedurende een week dagelijks 45 g amylomaize (62% 
resistant starch) of 45 g maltodextrine (0% resistant starch) toege-
voegd, zonder dat de proefpersonen of de onderzoekers wisten in 
welke volgorde dat gebeurde. 
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Deze hoeveelheid resistant starch werd goed verdragen en veroor-
zaakte uitsluitend enige toename van de winderigheid. De uitademing 
van waterstof gedurende 24 uur nam bij alle vrijwilligers significant 
toe tijdens resistant starch toevoeging en bij de methaan produceren-
de proefpersonen nam ook de methaan uitscheiding significant toe ten 
opzichte van de maltodextrine periode. Deze stijging van de uitschei-
ding van waterstof en methaan betekent dat de fermentatie in de 
dikke darm inderdaad toeneemt na consumptie van resistant starch. 
HET EFFECT VAN RESISTANT STARCH OP DE DIKKE DARM. 
Tenslotte werd bij gezonde vrijwilligers een onderzoek gedaan naar de 
veranderingen die door de toegenomen fermentatie tijdens amylomai-
ze consumptie in de dikke darm veroorzaakt worden. Hierbij waren wij 
geïnteresseerd in veranderingen in faeces gewicht, in de uitscheiding 
van galzuren in de faeces, in de cytotoxiciteit van het faecaal water 
en in de delingssnelheid van het dikke darmslijmvlies. Deze prolife-
ratie-activiteit is een maat voor de celdeling in de dikke darmcryptes. 
De resultaten van deze studie zijn beschreven in hoofdstuk 8. 
Aan de normale voeding van 14 gezonde vrijwilligers werd gedurende 
2 weken dagelijks 45 g amylomaize (62% resistant starch) toege-
voegd. Voorafgaand aan en op het einde van de periode van deze 
toevoeging werden ademmonsters en faeces van 3 dagen verzameld; 
tevens werden kleine weefsel-biopsiën uit de endeldarm genomen om 
de proliferatie-activiteit te meten. 
Net als in de voorgaande studie werd gevonden dat de uitademing 
van waterstof significant toenam gedurende resistant starch con-
sumptie. Ook de uitscheiding van korte keten vetzuren in de ontla-
sting nam tijdens resistant starch gebruik toe, hetgeen eveneens wijst 
op een toegenomen fermentatie. De concentratie deoxycholzuur in 
het faecaal water verminderde met 50% tijdens de consumptie van 
resistant starch en de totale concentratie primaire galzuren in de 
ontlasting nam toe. Dit wijst op een remming van de omzetting van 
primaire in secundaire galzouten. Wij denken dat dit vooral veroor-
zaakt wordt doordat primaire galzuren neerslaan als gevolg de lagere 
pH door de toegenomen fermentatie in de dikke darm. Tenslotte werd 
ook een significant lagere cytotoxiciteit van het faecaal water 
vastgesteld, alsmede een verminderde proliferatie-activiteit van het 
slijmvlies. 
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Samenvattend toont deze studie aan dat toevoeging van resistant 
starch in de vorm van amylomaize een gunstig effect heeft op 
verschillende parameters die samenhangen met het ontstaan van 
dikke darmkanker. 
SAMENVATTING EN PERSPECTIEF. 
Concluderend blijkt uit deze studies dat resistant starch in de vorm 
van amylomaize goed wordt verdragen door gezonde vrijwilligers en 
dat consumptie ervan leidt tot een toegenomen fermentatie. De 
concentratie van opgeloste galzouten in de ontlasting neemt sterk af 
tijdens resistant starch gebruik en -mogelijk- hierdoor ook het cel-
beschadigend (cytotoxisch) effect van de ontlasting. Ook de delings-
snelheid van het dikke darmslijmvlies neemt af, naar we aannemen als 
gevolg van de verminderde cytotoxiciteit. 
Van deze factoren wordt aangenomen dat zij betrokken zijn bij het 
ontstaan van dikke darmkanker. De bevinding, dat deze factoren in 
gunstige zin beïnvloed worden tijdens amylomaize consumptie, maakt 
het aannemelijk dat ook de kans op dikke darmkanker hiermee kan 
worden beïnvloed. 
Een deel van de effecten van resistant starch is vergelijkbaar met die 
van vezels. Een belangrijk voordeel van resistant starch is dat het 
gemakkelijker in onze dagelijkse voeding kan worden geïntegreerd dan 
een grote hoeveelheid vezels. 
Een volgende stap in het onderzoek is het nagaan van de lange 
termijn-effecten van resistant starch toediening. Bij gezonde vrijwilli-
gers zal gekeken worden of de beschreven effecten blijvend aanwezig 
zijn. Verder zal bij mensen met een verhoogd risico op dikke darmge-
zwellen onderzocht worden of het ontstaan van poliepen en kanker 
inderdaad geremd kan worden door langdurige consumptie van 
resistant starch. 
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Het doen van een promotieonderzoek moet men zien als een hobby: 
het kost tijd, maar het is ook leuk om te doen. Voor velen is werk 
tevens hun hobby; een proefschrift is dus eigenlijk ook gewoon een 
stukje werk. Het leuke ervan is dat het je verder leert kijken dan je 
eigen vak breed is. Daarbij zijn een aantal mensen in het bijzonder 
behulpzaam geweest, die ik expliciet wil bedanken: 
Fokko Nagengast, onze samenwerking begon als assistent en chef de 
clinique op B5 en bereikte een voorlopig hoogtepunt in dit proef-
schrift. Op de meest ongelegen en ongeregelde momenten, vaak op 
de fiets naar huis, hadden we overleg en dat leidde tot prachtige 
ideeën en soms zelfs tot fraaie onderzoeken. Ik leerde van jou scopi-
eren, en de gastroenterologie à la van Tongeren. En daardoor was het 
moeilijk kiezen tussen blijven of naar den Bosch gaanl 
Jan Jansen, je komst naar Nijmegen gaf nieuwe impulsen aan het 
onderzoek binnen de afdeling. Hoewel deze studie wat buiten jouw 
directe gebied lag, werkte je elan aanstekelijk. Je 'laagdrempelige' 
manier van leidinggeven vormde mede de prima sfeer op de afdeling. 
Martijn Katan, je inbreng bij vooral hoofdstuk 7 heb ik zeer gewaar-
deerd. Het is even wennen als een goed artikel in zwart bij je ingele-
verd wordt en in rood terugkomt, maar het wordt er veel beter van! 
Prof Wargovich, dear Mike, thank you for giving me the opportunity 
to stay at the MD Anderson Institute in Houston in your lab, to learn 
the mysteries of proliferation markers. 
De vele proefpersonen die meewerkten aan het onderzoek ben ik zeer 
erkentelijk. Consumptie van 45 gram Hylon mag dan goed verdragen 
worden, het dagenlang verzamelen van ontlasting op droogijs moet 
beschouwd worden als een hele opgaaf. 
Keuzevakstudenten spelen een ondergewaardeerde rol bij het heden-
daagse promotieonderzoek. In het bijzonder wil ik Pieter Friederichs, 
Hilde de Boer, Margje Jansen, Natale Adamo en Marcel Twickler 
bedanken voor hun gemotiveerde inzet. 
De bepaling van galzouten en korte keten vetzuren middels een 
zogenaamde gaschromatograaf is voor een clinicus toch ingewikkeld. 
Ik ben blij dat Annie van Schaik en Albert Tangerman dat voor mij 
deden. 
Op Koos Diepenbroek en de overige medewerkers van het laboratori-
um van de afdeling Pathologische Anatomie kon ik altijd een beroep 
doen om steeds veel te kleine rectumbiopten zo aan te snijden dat 
coupes met fraaie, longitudinaal getroffen cryptes verkregen werden, 
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die gebruikt konden worden voor de PCNA-kleuring. 
De medewerkers van de afdeling gastroenterologie en centrale endo-
scopie ben ik dankbaar voor de prima werksfeer, wellicht het best 
gekarakteriseerd in de bulderende lach van Jan Salemans waarmee 
onze werkkamer zo vaak overvuld werd. 
Louwrens Davids bewees het bestaansrecht van de Apple, door 
daarmee de fraaie voorkant te ontwerpen. 
Aan Henk Festen laat ik de eer dat hij mij erop gewezen heeft dat 
werken in een groot perifeer ziekenhuis ook voordelen heeft, vooral 
ben ik hem dankbaar dat ik -altijd laat op de avond- welkom was om 
onder het genot van een glas wijn gebruik te maken van zijn laser-
printer. 
Verder ben ik allen die zich voornamen om dit boekje nu eens te lezen 
dankbaar voor deze intentie. Mijn eigen ervaring heeft mij geleerd dat 
het dankwoord en de nederlandse samenvatting al een hele opgave is. 
Mijn ouders ben ik werkelijk dankbaar dat zij mij leerden leren en 
leerden relativeren. Marie-José, Kim, Sanne en Marit leerden mij dat 
een proefschrift inderdaad een hobby is, vaak leuk, soms tijdrovend, 
maar dat er ook nog andere hobby's zijn. 
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Ivo van Munster werd geboren op 23 oktober 1956 te Nijmegen. Hij 
behaalde zijn VWO diploma aan het Canisius College - Mater Dei' te 
Nijmegen in 1975. Vanaf hetzelfde jaar studeerde hij geneeskunde 
aan de Katholieke Universiteit te Nijmegen. In 1982 behaalde hij zijn 
artsexamen, aansluitend daaraan werd hij tot 1987 opgeleid tot 
internist in het Academisch Ziekenhuis te Nijmegen (hoofd: prof. dr. 
A. van 't Laar). Vanaf 1 maart 1987 tot 1 mei 1993 was hij 
werkzaam op de afdeling Gastroenterologie van het Academisch 
Ziekenhuis te Nijmegen (hoofd tot 1 januari 1991 dr. JHM van 
Tongeren, vanaf 1 juni 1991 prof. dr. JBMJ Jansen). Op deze afdeling 
verrichtte hij onder leiding van prof. dr. SH Yap gedurende 1 Уг jaar 
onderzoek naar Hepatitis C, tot diens vertrek naar Leuven. Daarna 
werd het in deze dissertatie beschreven onderzoek gedaan. Tevens 
werd de auteur in deze periode opgeleid tot gastroenteroloog. 
Vanaf 1 mei 1993 is hij gevestigd in het Bosch Medicentrum, locatie 
Groot Ziekengasthuis te 's-Hertogenbosch, waar hij samenwerkt met 
dr. JThM Burghouts, dr. JLJ Jansen, dr. Ml Kooien, dr. RMA 
Kurstjens, FJHM van Liebergen, PM Netten en dr. HPM Festen. Met 
laatstgenoemde beoefent hij speciaal de gastroenterologie. 
Hij is getrouwd met Marie-José van Herpen en vader van Kim, Sanne 
en Marit. 





